PFE logo

Pfizer Inc.

PFE
Healthcare|Drug Manufacturers - General|US
$29.39
-0.06 (-0.20%)
DCF Value
$37.35
Graham Number
$15.77
Cash / Share
$2.50

Clinical Trials (941)

TrialConditionsPhaseStatusEnrollmentDesignDrug
NCT06862219
A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer
Metastatic Urothelial Carcinoma
P4
Recruiting100Open-labelEnfortumab Vedotin
NCT07730450
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
COVID-19 Vaccines
P4
Recruiting200RCT, Open-labelBNT162b2 Vaccine, Tdap Vaccine
NCT03395197
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
mCRPC
P3
Active1,054RCT, Double-blindTalazoparib with enzalutamide, Placebo with enzalutamide
NCT05253651
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Colorectal Neoplasms
P3
Recruiting400RCT, Open-labeltucatinib, trastuzumab, bevacizumab, cetuximab, oxaliplatin, leucovorin, levoleucovorin, fluorouracil
NCT04821622
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Prostate Cancer
P3
Active599RCT, Double-blindtalazoparib plus enzalutamide, Placebo plus enzalutamide
NCT06012435
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
P3
Active762RCT, Open-labelsigvotatug vedotin, docetaxel
NCT02513394
PALbociclib CoLlaborative Adjuvant Study
Breast Cancer
P3
Active5,796RCT, Open-labelPalbociclib, Standard Adjuvant Endocrine Therapy
NCT07566156
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Urothelial Cancer, Urinary Bladder Neoplasms
P3
Recruiting390RCT, Open-labelEnfortumab vedotin, Cisplatin, Fluorouracil, Mitomycin C, Gemcitabine, Pembrolizumab
NCT05909397
Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer
Breast Cancer
P3
Active59RCT, Open-labelVepdegestrant (ARV-471/PF-07850327), Letrozole
NCT05911295
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
Urothelial Carcinoma
P3
Active412RCT, Open-labeldisitamab vedotin, pembrolizumab, gemcitabine, cisplatin, carboplatin
NCT02319837
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
Hormone Sensitive Prostate Cancer, Prostate Cancer
P3
Active1,068RCTEnzalutamide, Placebo (No longer applicable in Open Label study period), Leuprolide Open Label
NCT06650579
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
Recurrent Prostate Carcinoma, Stage III Prostate Cancer AJCC v8
P3
Recruiting72RCT, Double-blindAbiraterone Acetate, Bicalutamide, Leuprolide, Prednisone, Relugolix
NCT03975647
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer
HER2-positive Breast Cancer
P3
Active466RCT, Double-blindtucatinib, placebo, T-DM1
NCT05654623
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
Advanced Breast Cancer
P3
Active624RCT, Open-labelARV-471, Fulvestrant
NCT05132582
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
HER2 Positive Breast Cancer
P3
Active654RCT, Double-blindTucatinib, Trastuzumab, Pertuzumab, Combination product: Trastuzumab + Pertuzumab, Placebo
NCT06807281
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Atopic Dermatitis
P3
Recruiting450Open-labelAbrocitinib
NCT07846683
A Study to Assess the Efficacy and Safety of Subcutaneous Induction Therapy With Afimkibart in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
P3
Recruiting350RCT, Double-blindAfimkibart, Placebo
NCT05020236
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
P3
Recruiting893RCT, Open-labelElranatamab, Daratumumab, Pomalidomide, Dexamethasone
NCT03820830
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer
Breast Cancer Recurrent
P3
Active405RCT, Open-labelPalbociclib 125mg, Standard endocrine therapy
NCT07222800
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
P3
Recruiting800RCT, Double-blindPF-08634404, Bevacizumab, Chemotherapy
NCT03485209
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung
P2
Active350Open-labeltisotumab vedotin, pembrolizumab, carboplatin, cisplatin
NCT04579380
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Uterine Neoplasms, Uterine Cervical Neoplasms
P2
Active217Open-labeltucatinib, trastuzumab, fulvestrant
NCT03260023
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
HPV-Related Carcinoma, HPV-Related Cervical Carcinoma
P1P2
Active143RCT, Open-labelTG4001, Avelumab
NCT03297606
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
Lymphoma, Non-Hodgkin, Multiple Myeloma
P2
Recruiting720Open-labelOlaparib, Dasatinib, Nivolumab plus Ipilimumab, Axitinib, Bosutinib, Crizotinib, Palbociclib, Sunitinib, Temsirolimus, Erlotinib, Trastuzumab plus Pertuzumab, Vemurafenib plus Cobimetinib, Vismodegib, Tucatinib
NCT05868226
PRE-ISPY Phase I/II Oncology Platform Program
HER2-positive Breast Cancer, Metastatic Cancer
P1P2
Recruiting280Open-labelALX148, Fam-Trastuzumab Deruxtecan-Nxki, Zanidatamab, Tucatinib, TTX-MC138
NCT02960022
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
P2
Active900Open-labelenzalutamide, abiraterone acetate, prednisone, Leuprolide acetate
NCT06206837
A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
Breast Cancer
P1P2
Active71Open-labelvepdegestrant, PF-07220060
NCT03911973
Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers
TNBC - Triple-Negative Breast Cancer
P1P2
Active37Open-labelGedatolisib, Talazoparib
NCT06157892
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma
P2
Active54RCT, Open-labeldisitamab vedotin, tucatinib
NCT06330805
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8
P2
Recruiting70RCT, Open-labelLeuprolide, Relugolix
NCT03809000
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
Prostate Cancer
P2
Active188RCT, Open-labelEnzalutamide, Bicalutamide, GnRH analog
NCT07421700
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer
P1P2
Recruiting132Open-labelPF-08634404, Enfortumab Vedotin
NCT05548127
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
Breast Cancer
P1P2
Active37Open-labelARV-471, Abemaciclib
NCT04879329
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
P2
Recruiting372RCT, Open-labeldisitamab vedotin, pembrolizumab
NCT02693535
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
P2
Recruiting4,200Open-labelSunitinib (CLOSED TO ENROLLMENT), Trastuzumab and Pertuzumab (CLOSED TO ENROLLMENT), Vemurafenib and Cobimetinib (CLOSED TO ENROLLMENT), Olaparib (CLOSED TO ENROLLMENT), Nivolumab and Ipilimumab (CLOSED TO ENROLLMENT), Abemaciclib (CLOSED TO ENROLLMENT), Talazoparib (CLOSED TO ENROLLMENT), Atezolizumab and Talazoparib (CLOSED TO ENROLLMENT), Tucatinib plus Trastuzumab Subcutaneous (SC) (CLOSED TO ENROLLMENT), Futibatinib, Dabrafenib plus Trametinib, Fam-Trastuzumab Deruxtecan-Nxki (TDxD)
NCT05892068
A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain
Metastatic Breast Cancer
P2
Active9Open-labelTucatinib
NCT04430738
Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
Colorectal Carcinoma, Gastric Adenocarcinoma
P2
Active40Open-labeltucatinib, trastuzumab, oxaliplatin, leucovorin, fluorouracil, capecitabine, pembrolizumab
NCT05170334
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
Metastatic Uveal Melanoma
P2
Active7Open-labelBinimetinib, Belinostat
NCT05765500
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Prostate Cancer, Prostatic Neoplasms
P2
Recruiting110RCT, Single-blindRelugolix, Leuprolide
NCT04486352
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Endometrial Cancer
P1P2
Recruiting148Open-labelAtezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib, Talazoparib, Trastuzumab emtansine, Tiragolumab, Atezolizumab - 21 Day Cycle, Inavolisib, Letrozole, Giredestrant, Abemaciclib
NCT04901702
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Recurrent Solid Tumor, Recurrent Ewing Sarcoma
P1P2
Recruiting90RCT, Open-labelOnivyde, Talazoparib, Temozolomide
NCT01396408
A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
Advanced Rare Tumours
P2
Active137Open-labelSunitinib, Temsirolimus
NCT06106308
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
Metastatic Colorectal Cancer, CRC
P2
Active110RCT, Open-labelOnvansertib, FOLFIRI, Bevacizumab, FOLFOX
NCT03971409
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
Stage III Breast Cancer, Stage IIIA Breast Cancer
P2
Active145RCT, Open-labelAnti-OX40 Antibody PF-04518600, Avelumab, Binimetinib, Utomilumab, Liposomal Doxorubicin, Sacituzumab Govitecan
NCT07575932
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity
Overweight, Obesity
P2
Active940RCT, Double-blindPF-08653945, PF-08653944, Placebo
NCT06183489
Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
Smoldering Multiple Myeloma
P2
Active50Open-labelElranatamab
NCT04039230
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.
Breast Cancer
P1P2
Active75Open-labelTalazoparib, Sacituzumab Govitecan
NCT06966453
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Breast Cancer, Breast Neoplasms
P1P2
Active74Open-labelDisitamab vedotin
NCT05071937
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
Ovarian Cancer, Peritoneal Cancer
P2
Recruiting33Open-labelZEN003694, Talazoparib
NCT04227847
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Myelodysplastic Syndrome, Acute Myeloid Leukemia
P1
Active170Open-labelSEA-CD70, azacitidine, Venetoclax
NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck
P1
Recruiting1,006Open-labelsigvotatug vedotin, pembrolizumab, cisplatin, carboplatin
NCT04846478
Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC
Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
P1
Active35Open-labelTalazoparib, Tazemetostat
NCT06130995
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Androgen Deprivation Therapy, Locally Advanced Prostate Cancer
P1
Recruiting46Open-labelRelugolix and Enzalutamide
NCT03454035
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Tumor, Solid, Pancreatic Cancer
P1
Recruiting45Open-labelUlixertinib, Palbociclib
NCT05266105
A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients
Breast Cancer
P1
Active60Open-labelPalazestrant, Palbociclib
NCT05508906
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
Metastatic Breast Cancer, ER-positive Breast Cancer
P1
Active190Open-labelPalazestrant, Ribociclib, Alpelisib, Everolimus, Atirmociclib
NCT06131840
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung
P1
Recruiting914Open-labelPF-08046050, bevacizumab, 5-Fluorouracil (5-FU), Oxaliplatin, Leucovorin (LV)
NCT05208762
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck
P1
Recruiting714Open-labelPF-08046054, pembrolizumab
NCT07231991
A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function
Healthy Participants
P1
Recruiting24Open-labelvepdegestrant
NCT07519135
A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function
Healthy
P1
Recruiting26Open-labelPF-08653944
NCT07677358
A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease
Hepatic Impairment, Healthy, Hepatic Insufficiency
P1
Recruiting28Open-labelAtirmociclib
NCT07206225
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Non-muscle Invasive Bladder Cancer
P1
Recruiting294Open-labelPF-08052667, Sasanlimab, BCG, PF-02921367
NCT07754266
Headache Ear Auditory Dizziness Sinus (HEADS) Registry
Headache Disorders, Dizziness
Recruiting10,000——
NCT05198245
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
Migraine
Active1—Rimegepant, Various
NCT07332312
A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Recruiting71Open-label—
NCT05479721
LITMUS Imaging Study
NAFLD, NASH
Active450——
NCT01731353
FungiScope - A Global Emerging Fungal Infection Registry
Invasive Fungal Disease
Recruiting1,000——
NCT03870620
Metastatic Breast Cancer in Austria
Breast Cancer, Breast Carcinoma
Recruiting5,000——
NCT03275311
Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
Metastatic Breast Cancer
Recruiting42,000——
NCT05885009
Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)
Metastatic Prostate Cancer
Recruiting240——
NCT04998877
Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF Patients
Heart Failure With Preserved Ejection Fraction
Active60——
NCT04876781
Korean Post-marketing Surveillance for Xeljanz XR
Active Moderate to Severe Rheumatoid Arthritis, Active Ankylosing Spondylitis
Recruiting200—Tofacitinib XR
NCT03870919
Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients
Breast Cancer Stage IV, Radiotherapy
N/A
Active200Open-labelPalbociclib
NCT06647654
Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy
Respiratory Syncytial Virus, Respiratory Tract Diseases
Active1—ABRYSVO
NCT05189639
A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia
Acute Myeloid Leukemia
Recruiting165——
NCT05733104
A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea
Complicated Intra-abdominal Infection, Complicated Urinary Tract Infection
Recruiting600——
NCT00414115
National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children
Adverse Drug Reaction (ADR)
Recruiting7,000——
NCT06495164
A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer
Breast Cancer, Malignant Neoplasm of Breast
Active1—Palbociclib, Aromatase inhibitor, Ribociclib, Abemaciclib
NCT06864585
A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan
Infectious Diseases
Active59—Avibactam sodium/Ceftazidime hydrate
NCT00474175
Benzocaine Gel Toothache Dose-Response Study
Toothache
P4
Completed577RCT, Double-blindPlacebo gel, benzocaine, benzocaine
NCT01190007
Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients
Hypertension, Hypercholesterolemia
P4
Completed159Open-labelCaduet
NCT00297973
Cardiovascular Risk Assessment in Patients Treated With Caduet
Hypertension
P4
Completed1,442RCT, Open-label—
NCT00442325
Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets
Coronary Arteriosclerosis, Diabetes Mellitus, Type 2
P4
Completed595Open-labelAtorvastatin (Lipitor)
NCT02060487
Effects of Oral Sildenafil on Mortality in Adults With PAH
Pulmonary Arterial Hypertension
P4
Terminated385RCT, Double-blindsildenafil citrate, sildenafil citrate, sildenafil citrate
NCT00174395
A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine
Migraine
P4
Completed220RCT, Open-labeleletriptan
NCT00644800
A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis
Schizophrenia, Mania
P4
Completed89Open-labelZiprasidone
NCT00381095
A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer
Bone Neoplasms, Pain, Intractable
P4
Terminated152RCT, Double-blindPregabalin, Placebo
NCT00139776
Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"
Osteoarthritis, Knee, Osteoarthritis, Hip
P4
Completed875RCT, Double-blindCelecoxib, Celecoxib
NCT00323297
Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
P4
Completed105RCT, Double-blindBosentan, Bosentan, Sildenafil Citrate
NCT00645320
A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study
Pyschotic Disorders
P4
Completed75Open-labelZiprasidone
NCT00728988
Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome
Acute Coronary Syndrome
P4
Completed499RCT, Open-labelAtorvastatin, Atorvastatin
NCT00646841
Effects of Doxazosin Gastrointestinal Therapeutic System on Ambulatory Blood Pressure and Cardiovascular Risk Factors in Uncontrolled Hypertensive Patients
Hypertension
P4
Completed89Open-labelDoxazosin gastrointestinal therapeutic system (GITS)
NCT00640627
Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen
Osteoarthritis, Knee
P4
Completed380RCT, Double-blindCelecoxib, Placebo
NCT00143195
Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina
Myocardial Ischemia
P4
Completed200RCT, Open-labelAmlodipine, iso- 5 - mononitrate
NCT00143377
Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB
Urinary Incontinence
P4
Completed600RCT, Double-blindtolterodine SR, overactive bladder
NCT00147654
Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction
Urinary Incontinence
P4
Completed830RCT, Double-blindTolterodine ER 4 mg QD, Tamsulosin 0.4 mg QD
NCT00159679
Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy
Diabetic Neuropathy, Painful
P4
Completed167RCT, Double-blindPregabalin
NCT00137397
A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder
Urinary Incontinence
P4
Completed80RCT, Double-blindTolterodine ER, Placebo
NCT00359151
Celebrex Total Knee Arthroplasty Study
Osteoarthritis, Pain
P4
Terminated22RCT, Double-blindCelecoxib, Placebo
NCT00245596
Evaluation of the Index of Sexual Life Questionnaire
Impotence
P4
Completed120Open-labelsildenafil
NCT00994461
Study Of Celecoxib In Healthy Subjects
Healthy Volunteers
P4
Completed190RCT, Double-blindCelecoxib, Loxoprofen, Placebo
NCT00634985
Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs
Migraine
P4
Completed120Open-labeleletriptan
NCT01176968
Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction
Myocardial Infarction
P4
Completed1,012RCT, Double-blindEplerenone, Placebo
NCT00855738
A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice
Focal Epilepsy
P4
Completed111Open-labelGabapentin, Lamotrigine, Levetiracetam, Pregabalin, Oxcarbacepine, Tiagabine, Topiramate, Zonisamide
NCT00407537
Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors
Hypertension, Hypercholesterolemia
P4
Completed1,531RCT, Open-labelAmlodipine besylate/atorvastatin calcium single pill combination
NCT00807846
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
Arthritis, Juvenile Rheumatoid
P4
Completed201RCT, Double-blindCelecoxib, Naproxen
NCT00082589
The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure
Heart Failure, Congestive
P4
Completed250RCT, Double-blindEplerenone
NCT00645268
A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes
Erectile Dysfunction, Diabetes Mellitus, Type 2
P4
Completed300RCT, Double-blindsildenafil, placebo, sildenafil
NCT00230789
Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.
Urinary Incontinence
P4
Completed417Open-labelTolterodine ER 4 mg QD
NCT04741204
Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer
Breast Cancer Stage, Insulin Resistance
P4
Withdrawn—Open-labelMetformin Extended Release Oral Tablet
NCT00708370
A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.
Dyslipidemia
P4
Completed297RCT, Open-label—
NCT01977651
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
Metastatic Castration-resistant Prostate Cancer (mCRPC)
P4
Completed424Open-labelEnzalutamide
NCT00301262
Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied
Impotence
P4
Completed183RCT, Double-blindViagra (Sildenafil citrate)
NCT00430716
To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.
Pulmonary Arterial Hypertension
P4
Terminated130RCT, Double-blindSildenafil citrate, Sildenafil citrate, Sildenafil citrate, Sildenafil citrate
NCT01298466
Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain Study
Low Back Pain, Neuralgia
P4
Withdrawn—Open-labelPregabalin
NCT00159757
12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients
Schizophrenia
P4
Terminated150Open-labelziprazidone
NCT00644956
A Randomized, Open-Label, Crossover, Multicenter, Single Dose Comparator Study Evaluating Onset Of Penile Rigidity In Men With Erectile Dysfunction Who Are Treated With Sildenafil And Tadalafil
Erectile Dysfunction
P4
Completed56RCT, Open-labeltadalafil, sildenafil
NCT00644631
A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled, Flexible Dose Escalation Study To Evaluate Sexual And Relationship Satisfaction In The Female Partner Of Men With Erectile Dysfunction Treated With Sildenafil Citrate
Erectile Dysfunction
P4
Completed300RCT, Double-blindsildenafil, placebo
NCT01995513
Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients
Prostate Cancer
P4
Completed509RCT, Double-blindEnzalutamide, Abiraterone, Placebo for Enzalutamide, Prednisone
NCT00249730
Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function.
Impotence
P4
Completed510RCT, Double-blindSildenafil
NCT00654017
A Study Evaluating the Efficacy and Safety of Sildenafil in Patients With Erectile Dysfunction Receiving Hemodialysis
Erectile Disfunction, Hemodialysis
P4
Completed100RCT, Double-blindplacebo, sildenafil
NCT00477659
Neural Correlates In Mild Alzheimer's Disease
Alzheimer's Disease
P4
Completed14Open-labelDonepezil hydrochloride
NCT00245258
Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction
Impotence
P4
Completed312RCT, Double-blindSildenafil Citrate
NCT00894790
Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident
Pain
P4
Terminated8RCT, Open-labelCelecoxib, oral Diclofenac
NCT00648323
Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement
Prostate
P4
Completed80Open-labelDoxazosin mysylate GITS
NCT00631696
Evaluation Of Sperm Production With Healthy Male Volunteers Receiving Lyrica Or Placebo
Healthy
P4
Completed222RCT, Double-blindPregabalin, Placebo
NCT00159718
Double Blind Atorvastatin Amlodipine Study
Angina
P4
Completed360RCT, Double-blindamlodipine, atorvastatin
NCT00163150
Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke
Cerebrovascular Accident, Hypercholesterolemia
P4
Completed128RCT, Double-blindAtorvastatin
NCT00647101
A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma
Glaucoma, Open-Angle, Ocular Hypertension
P4
Completed600Open-labelLatanoprost
NCT00629681
A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia
Painful Diabetic Neuropathy and Post Herpetic Neuralgia
P4
Completed217Open-labelPregabalin
NCT00282932
Detrol LA In Men With Overactive Bladder.
Overactive Bladder (OAB)
P4
Completed600RCT, Double-blindDetrol LA
NCT00159900
Quality of Erection Study
Erectile Dysfunction
P4
Completed300RCT, Double-blindSildenafil Citrate
NCT00159692
Amlodipine Diabetic Hypertension Efficacy Response Trial
Hypertension
P4
Completed739RCT, Double-blindAmlodipine
NCT01020526
Pregabalin In Adolescent Patients With Fibromyalgia
Fibromyalgia
P4
Completed63Open-labelpregabalin
NCT00159666
Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia
Post-Herpetic Neuralgia
P4
Completed255RCT, Double-blindpregabalin
NCT00143260
Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose
Impotence
P4
Completed250RCT, Double-blindViagra (Sildenafil Citrate) 100 mg
NCT00351611
Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
Epilepsies, Partial
P4
Completed187RCT, Double-blindLyrica (pregabalin), placebo
NCT01455428
Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)
Postherpetic Neuralgia ( PHN )
P4
Completed223RCT, Double-blindLyrica (pregabalin), Placebo
NCT00174330
Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia
Hypertension, Hyperlipidemia
P4
Completed330RCT, Open-labelatorvastatin, amlodipine
NCT01322867
A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets
Healthy
P4
Completed30RCT, Open-labelalprazolam tablet, alprazolam oral solution
NCT00304772
Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients
Candidiasis, Sepsis
P4
Withdrawn—RCT, Single-blindFluconazole, Micafungin
NCT02918968
Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer
Prostate Cancer
P4
Completed206RCT, Open-labelEnzalutamide, Flutamide
NCT00640549
Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus
Hyperlipidemia, Diabetes Mellitus, Type 2
P4
Terminated41RCT, Double-blindAtorvastatin, Placebo
NCT00634348
A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients
Schizophrenia
P4
Completed256RCT, Double-blindAripiprazole, Ziprasidone
NCT00346216
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Arthritis, Rheumatoid
P4
Completed24,081RCT, Double-blindcelecoxib, Ibuprofen, Naproxen
NCT00156078
A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)
Diabetic Neuropathy, Painful
P4
Completed450RCT, Double-blindpregabalin
NCT00239109
Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.
Schizophrenia
P4
Completed112RCT, Double-blindZiprasidone, Olanzapine
NCT00635531
A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder
Panic Disorder
P4
Terminated16RCT, Double-blindalprazolam XR
NCT00677352
A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder
Panic Disorder
P4
Completed321RCT, Double-blindsertraline, Paroxetine
NCT00624780
Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder
Generalized Anxiety Disorder
P4
Completed615RCT, Double-blindPregabalin, Lorazepam, Pregabalin, Placebo
NCT00406315
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone
Schizophrenia, Schizoaffective Disorder
P4
Completed255Open-labelziprasidone
NCT00917644
Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet
Hypercholesterolemia
P4
Completed76RCT, Open-labelAtorvastatin
NCT00446797
Open Label Comparative Study On Celecoxib Efficacy And Safety Vs Non-Selective NSAID In Acute Pain Due To Ankle Sprain
Ankle Sprain
P4
Completed278RCT, Open-labelNon-selective NSAIDS, Celecoxib
NCT00644982
A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression
Depressive Disorder, Major
P4
Completed163RCT, Double-blindsertraline, venlafaxine XR
NCT00647543
Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand
Dyslipidemias
P4
Completed242Open-labelAtorvastatin, Atorvastatin, Atorvastatin
NCT01257542
Acute Cough Study In Children
Common Cold, Infections, Upper Respiratory Tract
P4
Terminated140RCT, Double-blindDextromethorphan, Placebo
NCT01642407
Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension, Hypertension, Pulmonary
P4
Completed6Open-labelSildenafil
NCT01727791
A Study Of Pregabalin (Lyrica) Drug Levels In Urine, Plasma And Breast Milk Of Healthy Lactating Women
Healthy Lactating Women
P4
Completed10Open-labelpregabalin (Lyrica)
NCT00645151
A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol
Dyslipidemias
P4
Completed512Open-labelAtorvastatin, Atorvastatin, Atorvastatin
NCT00571064
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Mild to Severe Alzheimer's Disease
P4
Completed97Open-labelDonepezil HCl
NCT00411437
Effects Of Detrol LA On Memory And Cognition In Elderly Population
Memory, Cognition
P4
Completed220RCT, Double-blindTolterodine ER, Oxybutynin ER
NCT00640432
Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain
Low Back Pain
P4
Completed244RCT, Double-blindDiclofenac, Celecoxib
NCT00468650
A Multicenter, Open Label, To Evaluate The Efficacy And Satisfaction Of Patrex® In Men With Erectile Dysfunction.
Erectile Dysfunction
P4
Completed117Open-labelsildenafil citrate
NCT01302938
Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder
Overactive Bladder
P4
Terminated18RCT, Double-blindTolterodine ER, Placebo
NCT00644748
A Study on the Efficacy and Safety of Gabapentin in the Treatment of Patients With Painful Diabetic Neuropathy
Diabetic Neuropathies
P4
Completed95Open-labelgabapentin
NCT00373685
GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)
Osteoarthritis
P4
Completed8,067RCT, Open-labelCelecoxib, Any commercially available NSAID with the indication for osteoarthritis
NCT00140049
A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma
Glaucoma, Open Angle, Ocular Hypertension
P4
Completed238RCT, Single-blindXalacom, Cosopt
NCT00151463
QEQ Treatment Responsiveness Evaluation Study
Impotence
P4
Completed100Open-labelsildenafil citrate
NCT00230568
EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)
Alzheimer's Disease
P4
Completed100Open-labelAricept
NCT00143481
Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women
Urinary Incontinence
P4
Completed400RCT, Double-blindTolterodine ER 4mg QD
NCT00174304
Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
Hypertension, Hyperlipidemia
P4
Completed1,120RCT, Open-labelAmlodipine/atorvastatin single pill
NCT00540293
Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study
Dyslipidemias
P4
Completed425Open-labelAtorvastatin
NCT00407797
Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial
Partial Seizures
P4
Terminated136Open-labelPregabalin
NCT00141427
Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.
Seizures
P4
Completed540Open-labelPregabalin
NCT00380874
Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer
Chemotherapy-Induced Peripheral Neuropathy
P4
Terminated64RCT, Double-blindPregabalin, Placebo
NCT00638807
Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen
Osteoarthritis, Knee
P4
Completed388RCT, Double-blindCelecoxib
NCT00654082
A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction
Spinal Cord Injury, Erectile Dysfunction
P4
Completed88RCT, Double-blindsildenafil, placebo
NCT02116582
A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Metastatic Castration-Resistant Prostate Cancer
P4
Completed215Open-labelEnzalutamide
NCT00632385
Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy
Migraine
P4
Completed127Open-labelEletriptan
NCT00143221
Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH)
Impotence
P4
Completed350RCT, Double-blindViagra, Placebo
NCT00640809
Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole
Bowel Diseases, Inflammatory
P4
Completed408RCT, Double-blindCelecoxib, Ibuprofen plus Omeprazole
NCT00648596
A Study to Evaluate Self-esteem and Relationships in Males With Erectile Dysfuntion
Erectile Dysfunction
P4
Completed780RCT, Double-blindsildenafil, placebo
NCT00666796
A Study to Assess the Pharmacodynamic Interaction Between Gabapentin and Ethanol in Healthy Subjects
Insomnia
P4
Completed20RCT, Double-blindPlacebo ethanol, Ethanol, Placebo, Gabapentin, Ethanol, Placebo, Gabapentin, Placebo ethanol
NCT00412113
A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk
Dyslipidemia, Hypertension
P4
Completed245RCT, Double-blindAmlodipine besylate, Amlodipine besylate/atorvastatin calcium single pill combination, Amlodipine besylate, Amlodipine besylate/atorvastatin calcium single pill combination
NCT00159809
Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile Dysfunction
Impotence, Depression
P4
Completed140RCT, Double-blindViagra (Sildenafil citrate)
NCT00634790
A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks
Panic Disorder
P4
Terminated49Open-labelalprazolam XR
NCT00219570
Dalacin-T Gel Post Approval Study
Acne Vulgaris
P4
Completed134RCT, Single-blindclindamycin, nadifloxacin
NCT00163202
Comparative Atorvastatin Pleiotropic Effects
Coronary Arteriosclerosis, Hypercholesterolemia
P4
Completed330RCT, Double-blindAtorvastatin
NCT00137072
Mild To Moderate Erectile Dysfunction Study
Impotence
P4
Completed355RCT, Double-blindViagra (Sildenafil Citrate) 100 mg
NCT00484718
Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib.
Osteoarthritis
P4
Terminated6RCT, Double-blindcelecoxib, Oxycodone, placebo
NCT00889720
A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery
Smoking Cessation
P4
Completed16Open-labelVarenicline
NCT00153972
Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease
Parkinson's Disease
P4
Completed39RCT, Single-blindCabergoline, Levodopa
NCT00548262
This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis
Candidemia, Invasive Candidiasis
P4
Completed54Open-labelAnidulafungin, Voriconazole
NCT05329259
A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India
Pneumococcal Disease
P4
Completed200Open-label13-valent pneumococcal conjugate vaccine
NCT01068873
Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)
HIV Infections
P4
Terminated1Open-labellopinavir/ritonavir plus maraviroc
NCT01061697
Pregabalin and Radicular Pain Study (PARPS)
Cervical Spondylosis, Cervical Spondylotic Myelopathy
P4
Completed50Open-labelPregabalin
NCT05518123
Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications
Migraine
P4
Completed962RCT, Double-blindRimegepant, Placebo
NCT00344019
Effects of Atorvastatin on Myonecrosis
Coronary Disease
P4
Terminated97RCT, Double-blindPlacebo Oral Tablet, Atorvastatin 80mg
NCT02307825
Azithromycin for Patients With Chronic Rhinosinusitis Failing Medical and Surgical Therapy
Chronic Rhinosinusitis, High-risk Patient
P4
Completed129RCT, Double-blindAzithromycin, Placebo
NCT00307944
Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea
Acid Reflux Disease, Obstructive Sleep Apnea
P4
Completed68RCT, Double-blindPantoprazole
NCT02415400
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
Acute Coronary Syndromes
P4
Completed4,614RCT, Open-labelApixaban, vitamin K antagonist, Acetylsalicylic acid
NCT00138060
Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants
Metastatic Colorectal Cancer
P4
Completed71Open-labelirinotecan, 5 fluorouracil
NCT00496197
Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis
Candidiasis
P4
Completed282Open-labelEraxis (anidulafungin), Diflucan (fluconazole), Vfend (voriconazole)
NCT01350596
A Bioequivalence Study Of Ibuprofen 50mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form.
Healthy
P4
Completed24RCT, Open-labelAlivium®, Ibuprofen
NCT00195507
Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis
Psoriasis
P4
Completed720RCT, Open-labelEtanercept
NCT03937609
TITRATE (inducTIon for acuTe ulceRATivE Colitis)
Colitis, Ulcerative
P4
Terminated50RCT, Open-labelInfliximab
NCT00276107
Study Evaluating Prevenar Vaccine in Healthy Infants
Pneumococcal Infections
P4
Completed200Open-labelPrevenar
NCT00194090
Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk
Knee Osteoarthritis
P4
Completed40RCT, Double-blindcelecoxib
NCT01721408
A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection
Intra-abdominal Infection
P4
Completed470RCT, Double-blindTigecycline, Imipenem/cilastatin
NCT00354445
A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD
Age-Related Macular Degeneration (AMD)
P4
Unknown1,000Open-labelpegaptanib sodium (Macugen)
NCT00936065
Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis
Moderate to Severe Psoriasis
P4
Completed60RCT, Open-labelEtanercept, Etanercept + Acitretin, Acitretin
NCT01056289
Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)
Major Depressive Disorder
P4
Completed480RCT, Double-blindDesvenlafaxine Succinate Sustained-Release Formulation 50 mg, Desvenlafaxine Succinate Sustained-Release Formulation 25 mg, Placebo
NCT00649090
A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer
Breast Neoplasms
P4
Completed1,549Open-labelexemestane
NCT05080218
COVID-19 VaccinE Response in Rheumatology Patients
Rheumatoid Arthritis, Psoriatic Arthritis
P4
Completed841RCT, Open-labelUpadacitinib, Abatacept, Secukinumab, Tofacitinib, TNF Inhibitor, Canakinumab Injection, Baricitinib, Ixekizumab
NCT02819921
Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen
Hot Flashes, Breast Neoplasms
P4
Terminated59RCT, Double-blindDesvenlafaxine succinate 100mg, Desvenlafaxine succinate 50mg, Placebo
NCT00139724
Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet
Urinary Incontinence
P3
Completed260RCT, Double-blindtolterodine extended release capsule
NCT00954590
A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease
Moderate to Severe Alzheimer
P3
Terminated89RCT, Double-blindDimebon (latrepirdine), Placebo
NCT01113541
One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome
Bipolar Disorder
P3
Terminated13Open-labelZiprasidone HCL (oral)
NCT00596466
Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures
Epilepsy
P3
Completed75Open-labelpregabalin
NCT00905437
Study To Investigate The Effectiveness Of Pregabalin For Management Of Patients Undergoing Total Hip Replacement
Pain, Perioperative
P3
Terminated72RCT, Double-blindPlacebo, Pregabalin
NCT00800267
A Study of Glaucoma or Ocular Hypertension in Patients Within the United States
Ocular Hypertension, Glaucoma
P3
Completed418RCT, Double-blindlatanoprost 0.005%, fixed combination latanoprost-timolol, timolol 0.5%
NCT00716859
A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.
Glaucoma
P3
Completed139RCT, Double-blindTimolol, latanoprost
NCT00383019
A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).
Glaucoma, Ocular Hypertension
P3
Completed300RCT, Double-blindXalatan, Xalacom
NCT01270828
Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
Post Herpetic Neuralgia
P3
Completed806RCT, Double-blindPregabalin, placebo
NCT00151450
Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder
Anxiety
P3
Completed390RCT, Double-blindPregabalin, Venlafaxine XR
NCT00143130
Pregabalin In Partial Seizures Extension Study
Seizures
P3
Completed227Open-labelPregabalin
NCT00159887
Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension
Pulmonary Hypertension
P3
Completed260Open-labelSildenafil citrate
NCT01152216
An Extension of the CONCERT Protocol (DIM18)
Alzheimer's Disease
P3
Terminated672Open-labelDimebon
NCT02288247
A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone
Metastatic Castration Resistant Prostate Cancer
P3
Completed688RCT, Double-blindEnzalutamide, Docetaxel, Prednisolone, Placebo
NCT00974311
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
Castration-Resistant Prostate Cancer
P3
Completed1,199RCT, Double-blindEnzalutamide, Placebo
NCT00806026
Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients
Idiopathic Restless Legs Syndrome
P3
Completed731RCT, Double-blindplacebo and pregabalin, pramipexol, pramipexol, Pregabalin, pramipexol, pramipexol
NCT00150306
A Ten-Week Study Evaluating The Effectiveness And Safety Of Zoloft In Children And Adolescents With A Diagnosis Of PTSD
Stress Disorders, Post-Traumatic
P3
Terminated160RCT, Double-blindZoloft (Sertraline)
NCT00666770
A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance
Transient Insomnia
P3
Completed309RCT, Double-blindGabapentin, Gabapentin, Placebo
NCT00415623
A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient
Hypertension
P3
Completed305RCT, Double-blindAmlodipine, Amlodipine
NCT01202227
An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain
Spinal Cord Diseases, Spinal Cord Injuries
P3
Completed104Open-labelpregabalin
NCT00143156
Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Neuropathies
P3
Completed450RCT, Double-blindpregabalin
NCT00407745
A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury
Neuralgia, Spinal Cord Injuries
P3
Completed220RCT, Double-blindplacebo, pregabalin
NCT00219596
Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension
Glaucoma, Open Angle, Ocular Hypertension
P3
Completed240RCT, Open-labelXalacom, unfixed Latanoprost and Timolol
NCT00159861
The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH
Pulmonary Hypertension
P3
Completed267RCT, Double-blindSildenafil citrate
NCT00330785
Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
Hypertension, Dyslipidemia
P3
Completed1,250Open-labelAmlodipine/Atorvastatin
NCT00551135
Surgical Pain After Inguinal Hernia Repair (SPAIHR)
Pain, Postoperative, Hernia, Inguinal
P3
Completed425RCT, Double-blindPregabalin, placebo, Pregabalin, Pregabalin
NCT01864746
A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery
Breast Cancer, Hormonreceptor Positive
P3
Completed1,250RCT, Double-blindPalbociclib PD-0332991, Placebo
NCT00762463
Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis
Ankylosing Spondylitis
P3
Completed240RCT, Double-blindCelecoxib, Diclofenac SR
NCT00219544
Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.
Neuropathic Pain
P3
Completed158RCT, Double-blindPregabalin (Lyrica), Pregabalin (Lyrica), Pregabalin (Lyrica), Placebo
NCT01986270
Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo
Migraine With or Without Aura
P3
Completed1,141RCT, Double-blindPlacebo, Eletriptan 40 mg, Eletriptan 80 mg, Sumatriptan 25 mg, Sumatriptan 50 mg
NCT00141271
A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression
Bipolar Disorder
P3
Completed536RCT, Double-blindGeodon (Ziprasidone), Geodon (Ziprasidone), Placebo
NCT00232141
Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy
HIV Infections, Peripheral Neuropathy
P3
Completed302RCT, Double-blindpregabalin, Placebo
NCT01057693
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
Diabetic Neuropathy, Painful
P3
Completed633RCT, Double-blindpregabalin (Lyrica), Placebo
NCT01701362
Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain
Neuropathic Pain
P3
Completed542RCT, Double-blindpregabalin, placebo
NCT00401362
A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients
Advanced Illness Patients With Opioid Induced Constipation
P3
Completed154RCT, Double-blindSC Methylnaltrexone, SC Placebo, SC Methylnaltrexone
NCT00139737
Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia
Schizophrenia
P3
Completed344Open-labelZiprasidone
NCT00163046
A 28-Day Polysomnographic Study of Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance
Transient Insomnia
P3
Completed256RCT, Double-blindGabapentin, Placebo
NCT00312494
3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
Bipolar Disorder
P3
Completed680RCT, Double-blindPlacebo, Ziprasidone, Ziprasidone
NCT01117220
Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)
Bipolar Disorder
P3
Withdrawn—RCT, Double-blindPlacebo, Ziprasidone Oral Capsules
NCT00830128
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin In Patients With Fibromyalgia
Fibromyalgia
P3
Completed106Open-labelpregabalin (Lyrica)
NCT00150280
Compare Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological Surgery
Pain, Postoperative
P3
Completed132RCT, Double-blindcelecoxib and ibuprofen SR
NCT00827606
Atorvastatin Three Year Pediatric Study
Familial Hypercholesterolemia
P3
Completed272Open-labelatorvastatin
NCT03768726
Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder
Bipolar Disorder
P3
Terminated23Open-labelZiprasidone, Placebo
NCT00645372
A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients
Schizophrenia
P3
Completed242RCT, Double-blindRisperidone, Ziprasidone
NCT00468845
Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy
Pain, Postoperative
P3
Completed501RCT, Double-blindpregabalin (Lyrica), pregabalin (Lyrica), matched placebo
NCT00829374
Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Alzheimer's Disease
P3
Completed1,003RCT, Double-blindDimebon, Dimebon, Placebo comparator
NCT00751062
A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia
Open Angle Glaucoma, Ocular Hypertension
P3
Completed267RCT, Double-blindtimolol, PhXA41
NCT00280059
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
Epilepsy, Partial
P3
Completed660RCT, Double-blindPregabalin, Lamotrigine
NCT00644605
A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension
Hypertension, Pulmonary
P3
Completed275RCT, Double-blindsildenafil, sildenafil, placebo, sildenafil
NCT00354081
WENBIT - Western Norway B Vitamin Intervention Trial
Coronary Artery Disease, Myocardial Infarction
P3
Completed3,096RCT, Double-blindfolic acid, vitamin B12 (cyanocobalamin), vitamin B6 (pyridoxine), folic acid, vitamin B12 (cyanocobalamin), vitamin B6 (pyridoxine), placebo
NCT01485887
Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
Major Depressive Disorder
P3
Completed50Open-labelVenlafaxine ER
NCT00282464
A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.
Bipolar Disorder
P3
Completed392RCT, Double-blindPlacebo, Geodon (Ziprasidone)
NCT00666939
A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase Advance
Transient Insomnia
P3
Completed773RCT, Double-blindGabapentin, Gabapentin, Placebo
NCT00401375
Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI)
Post-Operative Ileus (POI)
P3
Completed524RCT, Double-blindMethylnaltrexone, Placebo
NCT00645515
A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia
Schizophrenia
P3
Terminated240RCT, Double-blindZiprasidone, Risperidone
NCT00723606
A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation
Schizophrenia
P3
Completed376RCT, Open-labelIntramuscular ziprasidone mesylate, Intramuscular haloperidol
NCT00448916
Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
Epilepsies, Partial
P3
Completed54Open-labelPregabalin
NCT01271933
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
Fibromyalgia
P3
Completed441RCT, Double-blindpregabalin, placebo
NCT01978496
Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine
Migraine With or Without Aura
P3
Completed1,334RCT, Double-blindPlacebo, Eletriptan 20 mg, Eletriptan 40 mg, Eletriptan 80 mg
NCT00147615
The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years
Hypertension
P3
Completed140Open-labelEplerenone
NCT01049217
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
Neuropathy
P3
Terminated377RCT, Double-blindpregabalin, placebo
NCT00553280
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Neuropathy, Painful
P3
Completed123Open-labelpregabalin
NCT00301223
A Study to Assess the Efficacy, Safety and Tolerability of Pregabalin in Patients With Symptoms of Neuropathic Pain
Neuropathic Pain
P3
Completed309RCT, Double-blindPregabalin
NCT00141258
Pregabalin Epilepsy Add-On Trial
Partial Seizures
P3
Completed178RCT, Double-blindpregabalin
NCT01145417
Pregabalin Trial In HIV Neuropathic Pain
HIV-1 Infection, Neuropathic Pain
P3
Terminated217Open-labelpregabalin (Lyrica)
NCT00151528
An Open-Label Trial of Pregabalin in Patients With Fibromyalgia
Fibromyalgia
P3
Completed428Open-labelPregabalin
NCT01474772
Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)
Diabetic Peripheral Neuropathy
P3
Completed217RCT, Double-blindPregabalin
NCT00372528
An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures
Epilepsy
P3
Terminated21Open-labelpregabalin (LYRICA)
NCT01085266
An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease
Huntington Disease
P3
Terminated362Open-labelDimebon (latrepirdine)
NCT00163241
Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression
Osteoarthritis
P3
Terminated666RCT, Double-blindcelecoxib
NCT01262677
Once-A-Day Pregabalin For Partial Seizures
Partial Seizures, Epilepsies, Partial
P3
Completed325RCT, Double-blindpregabalin, pregabalin, pregabalin, pregabalin, pregabalin, pregabalin, placebo
NCT00553475
Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Neuropathy, Painful
P3
Completed314RCT, Double-blindplacebo, pregabalin, pregabalin
NCT00649844
A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs
Schizophrenia
P3
Completed147RCT, Double-blindClozapine, Ziprasidone
NCT02072824
A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.
Partial Onset Seizures
P3
Completed175RCT, Double-blindPregabalin Dose Level 1, Pregabalin Dose Level 2, Placebo
NCT00265382
Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia
Schizophrenia
P3
Terminated221Open-labelZiprasidone oral capsules
NCT00136994
IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)
Schizophrenia
P3
Completed160Open-labelZiprasidone
NCT06218069
Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor
NSCLC
P2P3
Not Yet Recruiting20Open-labelSasanlimab, [89Zr]Zr-crefmirlimab berdoxam
NCT01859481
Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study
Migraine Without Aura, Migraine With Aura
P3
Completed971RCT, Double-blindPlacebo, Eletriptan HBr 40 mg, Eletriptan HBr 80 mg
NCT04424511
Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in Mali
Mortality
P3
Completed149,201RCT, Double-blindPlacebo, Azithromycin
NCT00856622
A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients
Ocular Hypertension, Glaucoma
P3
Completed436RCT, Double-blindi. Fixed combination of latanoprost 0.005% and timolol 0.5%, timolol 0.5% ophthalmic solution, latanoprost 0.005% ophthalmic solution
NCT00530946
A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin
Hypertension, Hypercholesterolemia
P3
Completed165RCT, Open-labelAmlodipine 2.5mg/Atorvastatin 5mg, Amlodipine 2.5mg/Atorvastatin 10mg, Amlodipine 5mg/Atorvastatin 5mg, Amlodipine 5mg/Atorvastatin 10mg
NCT00159770
Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
Schizophrenia, Schizoaffective Disorder
P3
Completed290RCT, Open-labelziprasidone versus olanzapine , risperidone or quetiapine
NCT00265330
Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
Bipolar Disorder
P3
Completed169Open-labelZiprasidone oral capsules
NCT01332149
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
Diabetic Neuropathy, Painful
P3
Completed626RCT, Double-blindPregabalin, Placebo matched with pregabalin
NCT00976716
An Open-Label Study Of Celecoxib In Patients With Posttraumatic Pain
Pain
P3
Completed80Open-labelCelecoxib
NCT01945775
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)
Breast Neoplasms, BRCA 1 Gene Mutation
P3
Completed431RCT, Open-labeltalazoparib, Physician's-Choice
NCT00667108
A Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance
Transient Insomnia
P3
Completed784RCT, Double-blindGabapentin, Gabapentin, Placebo
NCT01432236
A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression
Fibromyalgia
P3
Completed197RCT, Double-blindPregabalin, placebo
NCT00151489
Safety and Efficacy Study of Pregabalin in Fibromyalgia
Fibromyalgia
P3
Completed1,020RCT, Double-blindpregabalin, placebo
NCT00912288
A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease
Alzheimer Disease
P3
Terminated86RCT, Double-blindDimebon 20 mg po TID, Placebo po TID
NCT02075047
Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
Bipolar Disorder
P3
Terminated171RCT, Double-blindplacebo oral capsules, ziprasidone oral capsules
NCT00174447
Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031
Schizophrenia
P3
Completed43Open-labelZiprasidone
NCT00230763
Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure
Glaucoma, Primary Open Angle (POAG), Ocular Hypertension
P3
Completed396Open-labelLATANOPROST 0.005% / TIMOLOL 0.5% FIXED COMBINATION
NCT01212991
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
Prostate Cancer
P3
Completed1,717RCT, Double-blindEnzalutamide, Placebo
NCT00232180
A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines
Heart Failure
P3
Completed2,743Open-labelEplerenone
NCT03447132
Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant
Breast Neoplasm Female
P3
Completed354RCT, Double-blindFulvestrant 500mg, Palbociclib 125mg, Goserelin 3.6 MG, Placebos
NCT00920946
A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease
Huntington Disease
P3
Completed403RCT, Double-blindDimebon
NCT01389596
A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years
Epilepsy, Partial Seizures
P3
Completed295RCT, Double-blindPregabalin add-on therapy, Pregabalin add-on therapy, Pregabalin add-on therapy
NCT01115855
Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure
Heart Failure
P3
Completed221RCT, Double-blindEplerenone, Placebo
NCT01989936
Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan
Migraine With or Without Aura
P3
Completed446RCT, Double-blindPlacebo, Eletriptan 40 mg, Eletriptan 80 mg
NCT00549549
Celebrex In Acute Gouty Arthritis Study
Arthritis, Gouty
P3
Completed402RCT, Double-blindIndomethacin, Celecoxib, Celecoxib, Celecoxib
NCT02929576
Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer
Breast Cancer
P3
Withdrawn—RCT, Double-blindEnzalutamide, Placebo, Paclitaxel
NCT04501978
ACTIV-3: Therapeutics for Inpatients With COVID-19
Covid19
P3
Completed2,753RCT, Double-blindLY3819253, Placebo, Remdesivir, VIR-7831, BRII-196/BRII-198, AZD7442, MP0420, PF-07304814
NCT00751049
A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom
Ocular Hypertension, Open Angle Glaucoma
P3
Completed294RCT, Double-blindtimolol, PhXA41
NCT01061372
12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects
Restless Legs Syndrome
P3
Withdrawn—RCT, Double-blindPlacebo, pregabalin, pregabalin
NCT00159653
A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma
Glaucoma, Open-Angle, Ocular Hypertension
P3
Completed500RCT, Double-blindXalacom, Xalatan, Timolol
NCT00754052
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Down Syndrome, Cognitive Dysfunction
P3
Terminated8RCT, Double-blindAricept (donepezil hydrochloride), Aricept (donepezil hydrochloride), Placebo
NCT01066546
An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease
Alzheimer's Disease
P3
Terminated5Open-labelDimebon tablet for oral administration
NCT01248416
Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature
Idiopathic Short Stature
P3
Completed76RCT, Open-labelAromatase Inhibitor, Growth Hormone, Aromatase Inhibitor and Growth Hormone
NCT00838110
A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease
Alzheimer's Disease
P3
Completed742RCT, Double-blindDimebon, Placebo, Dimebon, Placebo
NCT00159913
A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.
Pulmonary Arterial Hypertension, Children
P3
Completed235RCT, Double-blindSildenafil citrate, Sildenafil citrate, Placebo, Sildenafil citrate
NCT00804141
Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation
Constipation
P3
Completed1,040Open-labelN-methylnaltrexone bromide (MOA-728)
NCT00141154
Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan
Low Back Pain
P3
Completed1,234RCT, Double-blindCelecoxib, Placebo, Loxoprofen
NCT00346034
This Study is An Open-Label Trial Of Pregabalin In Patients With Fibromyalgia
Fibromyalgia
P3
Completed357Open-labelPregabalin
NCT00368745
Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use.
Generalized Anxiety Disorder
P3
Completed108RCT, Double-blindPregabalin, Placebo
NCT00442546
Efficacy And Safety Of Pregabalin For Pain Following Total Knee Replacement
Osteoarthritis, Postoperative Pain
P3
Completed307RCT, Double-blindpregabalin, pregabalin, Placebo
NCT00939783
An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease
Alzheimer's Disease
P3
Terminated649Open-labelDimebon
NCT00631943
A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain
Neuralgia
P3
Completed112Open-labelPregabalin (Lyrica)
NCT00159874
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
Pulmonary Arterial Hypertension
P3
Completed234RCT, Open-labelSildenafil citrate, Sildenafil citrate, Sildenafil citrate
NCT00883740
Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia
Fibromyalgia, Sleep Disorders
P3
Completed119RCT, Double-blindPregabalin, Placebo
NCT00343655
Evaluation of Atorvastatin Treatment on Carotid Plaque.
Cardiovascular Diseases
P3
Terminated160RCT, Double-blindAtorvastatin
NCT01986088
Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study
Migraine With or Without Aura
P3
Completed1,008RCT, Double-blindPlacebo, Eletriptan 40 mg, Eletriptan 80 mg, Sumatriptan 50 mg, Sumatriptan 100 mg
NCT00143234
Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels
Hypertension, Hyperlipidemia
P3
Completed1,825Open-labelAmlodipine/atorvastatin single pill
NCT00394901
A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia
Neuralgia, Postherpetic
P3
Completed372RCT, Double-blindPlacebo, Pregabalin, Pregabalin, Pregabalin
NCT00007657
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
Myocardial Ischemia
P3
Completed3,260RCT, Open-label—
NCT02504294
A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis
Chronic Kidney Disease (CKD)
P3
Completed432RCT, Open-labelEpoetin Hospira Arm, IV Iron
NCT00630851
A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes
Alzheimer Disease
P3
Completed249RCT, Double-blindDonepezil (Aricept), Placebo
NCT00470665
Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients
Renal Allograft Recipients
P3
Completed460RCT, Open-labelRapamune
NCT00252967
Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)
Atrial Fibrillation, Inflammation
P3
Terminated64RCT, Double-blindAtorvastatin, Placebo
NCT01008605
Caverject User Study
Erectile Dysfunction
P3
Completed48Open-label—
NCT00500357
Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects
Vaccines, Pneumococcal Conjugate Vaccine
P3
Completed105Open-label13-valent Pneumococcal Conjugate Vaccine
NCT05632354
GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD)
Sickle Cell Disease
P2P3
Terminated47Open-labelOsivelotor
NCT01232556
A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
Lymphoma, Non-Hodgkin
P3
Terminated338RCT, Open-labelInotuzumab ozogamicin, Rituximab, rituximab + gemcitabine, rituximab +bendamustine
NCT01500551
Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis
P2P3
Completed302Open-labelTofacitinib, Tofacitinib
NCT04218084
Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease
Sickle Cell Disease
P3
Terminated236RCT, Double-blindVoxelotor, Placebo
NCT01360372
Effect of Methylnaltrexone (Relistor) on Digestion and Tolerance to Tube Feeding in Patients Treated With Opiates
Tube Feeding
P3
Withdrawn—RCT, Double-blindMethylnaltrexone, Saline injection
NCT07300839
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
COVID-19, SARS-COV-2 Infection
P3
Completed5,240RCT, Double-blindBNT162b2 Vaccine, Placebo
NCT01309737
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Psoriasis
P3
Completed960RCT, Double-blindCP-690,550, CP-690,550, Placebo/CP-690,550, Placebo/CP-690,550
NCT00650637
A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea
Diarrhea
P3
Terminated17RCT, Open-labelCalcium Carbonate, nelfinavir, lamivudine, loperamide, nelfinavir, lamivudine + zidovudine
NCT01169467
Cerebral Perfusion Pressure Using Precedex and Other Sedatives
Endotracheal Intubation, Continuous IV Sedation
P3
Completed89RCT, Double-blindStandard-of-Care plus Dexmedetomidine
NCT02718417
Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)
Ovarian Cancer
P3
Terminated998RCT, Open-labelcarboplatin, paclitaxel, Avelumab, Avelumab
NCT03235479
Safety and Efficacy Study in Adult Subjects With Acute Migraines
Migraine, With or Without Aura
P3
Completed1,485RCT, Double-blindRimegepant, Placebo
NCT05997290
A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals
SARS-CoV-2 Infection, COVID-19
P2P3
Completed1,051Open-labelBNT162b2 (Omi XBB.1.5), BNT162b2 (Omi JN.1), BNT162b2 (Omi KP.2)
NCT03796676
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
Atopic Dermatitis
P3
Completed287RCT, Double-blindPlacebo, PF-04965842, PF04965842
NCT00161876
FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years
Encephalitis, Tick-borne
P3
Completed3,973Open-labelTick-Borne Encephalitis (TBE) Vaccine (Inactivated)
NCT01806623
The Study Of Fluconazole For Vulvovaginal Candidiasis
Vulvovaginal Candidiasis
P3
Completed157Open-labelFluconazole
NCT00174382
Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia
Dementia, Vascular, Dementia, Mixed
P3
Terminated149Open-labelDonepezil
NCT01968954
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Hyperlipidemia
P3
Completed711RCT, Double-blindBococizumab (PF-04950615;RN316)
NCT00134173
A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease
Coronary Disease, Coronary Arteriosclerosis
P3
Completed1,100RCT, Double-blindtorcetrapib/atorvastatin, atorvastatin
NCT00138723
Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome
Overactive Bladder
P3
Completed—RCT, Double-blindSPM 907
NCT03732807
PF-06651600 for the Treatment of Alopecia Areata
Alopecia Areata
P2P3
Completed718RCT, Double-blindPF-06651600 Induction Dose, PF-06651600 Maintenance Dose #1, PF-06651600 Maintenance Dose #2, PF-06651600 Maintenance Dose #3, Placebo
NCT00205777
Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
Osteoporosis
P3
Completed7,609RCT, Double-blindBazedoxifene Acetate
NCT03573882
Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031
Sickle Cell Disease
P3
Terminated179Open-labelVoxelotor
NCT02528253
A Phase 3 Study of Tanezumab for Chronic Low Back Pain
Low Back Pain
P3
Completed1,832RCT, Double-blindPlacebo to Week 16; tanezumab 5mg SC, Placebo to Week 16, tanezumab 10 mg SC, Tanezumab 5 mg SC, Tanezumab 10 mg SC, Tramadol PR oral
NCT00285012
Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).
Smoking Cessation
P3
Completed504RCT, Double-blindplacebo, Varenicline Tartarate
NCT00432796
PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.
Stroke
P3
Unknown1,473RCT, Double-blindDalteparin
NCT00163527
Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)
Asthma
P3
Completed2,054RCT, Double-blindRoflumilast
NCT00546572
Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)
Pneumococcal Infections
P3
Completed938RCT, Double-blind13 valent Pneumococcal Conjugate Vaccine, 23vPS
NCT00391196
A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients
Obesity
P3
Terminated975RCT, Double-blindPlacebo, CP-945,598, CP-945,598 Treatment B
NCT00788177
Subretinal Macugen® for Neovascular Age-Related Macular Degeneration
Age-related Macular Degeneration
P3
Unknown10Open-labelPegaptanib (Macugen®)
NCT00795639
Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)
Pulmonary Arterial Hypertension, Pulmonary Hypertension
P3
Terminated183RCT, Double-blindSitaxsentan, Placebo
NCT00496769
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Atrial Fibrillation
P3
Completed6,421RCT, Double-blindApixaban, Acetylsalicylic acid
NCT00355589
Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
Hypertension, Blood Pressure, High
P3
Completed—RCT, Double-blindRamipril and hydrochlorothiazide
NCT00527397
Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes
Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1
P3
Terminated24Open-labelCP-464,005, CP-464,005, CP-464,005
NCT01975389
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
Cardiovascular Disease
P3
Terminated10,564RCT, Double-blindbococizumab (PF-04950615), Placebo
NCT01241591
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Psoriasis
P3
Completed1,101RCT, Double-blindCP 690,550 5 mg, CP 690,550 10 mg, Etanercept 50 mg
NCT00627003
A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS
Restless Legs Syndrome
P3
Completed43RCT, Double-blindCabergoline
NCT01882439
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Psoriatic Arthritis
P3
Completed395RCT, Double-blindTofacitinib, Tofacitinib, Tofacitinib, Tofacitinib
NCT00256685
Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause
Menopause, Hot Flashes
P3
Completed568RCT, Double-blindDVS-233 SR
NCT00868296
Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)
Gastroesophageal Reflux
P3
Completed58Open-labelpantoprazole
NCT01438918
X-Ray Study Investigating The Safety And Efficacy Of SD-6010 In Subjects With Osteoarthritis Of The Knee
Knee Osteoarthritis
P3
Withdrawn—RCT, Double-blindSD-6010, SD-6010, Placebo
NCT00150267
A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension
Glaucoma, Open-Angle, Ocular Hypertension
P3
Completed976Open-labelXalacom
NCT04713553
A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants
SARS-CoV-2 Infection, COVID-19
P3
Completed1,574RCT, Double-blindBNT162b2, BNT162b2.B.1.351
NCT00643734
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients
Pneumonia
P3
Completed468RCT, Double-blindazithromycin sustained release, levofloxacin
NCT03423199
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
Breast Neoplasms
P3
Unknown180RCT, Double-blindPalbociclib, Placebo, Tamoxifen, Goserelin
NCT00625872
Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy
Growth Hormone Therapy, Infant, Small for Gestational Age
P3
Terminated23RCT, Open-labelSomatropin, Somatropin
NCT00161928
Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants
Meningitis, Meningococcal
P3
Completed330RCT, Open-labelGroup C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine (GCMP-TT)
NCT01112865
Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects
Growth Hormone Deficiency
P3
Completed120RCT, Open-label—
NCT00675688
Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women
Endometrial Hyperplasia, Osteoporosis
P3
Completed3,544RCT, Double-blindBazedoxifene/Conjugate Estrogens (CE), Raloxifene, Placebo
NCT00645242
A Study Of Diflucan In Children With Ringworm Of The Scalp
Tinea Capitis
P3
Completed185Open-labelfluconazole
NCT01033760
Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)
HIV-1 Infections
P3
Completed90RCT, Open-labelraltegravir; maraviroc; darunavir; ritonavir; tenofovir/emtricitabine, darunavir; ritonavir; emtricitabine/tenofovir
NCT00471146
Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
Carcinoma, Pancreatic Ductal
P3
Completed630RCT, Double-blindAG-013736, Gemcitabine, Gemcitabine, placebo
NCT00192283
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers
Influenza
P3
Completed2,903RCT, Double-blindCAIV-T
NCT04230213
A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis
Rheumatoid Arthritis
P3
Completed455RCT, Open-labelPF-06410293, adalimumab
NCT00134238
Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
Mixed Hyperlipidemia
P3
Terminated755RCT, Double-blindtorcetrapib/atorvastatin, atorvastatin
NCT00754221
Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia
Fibromyalgia
P3
Terminated390Open-label[S,S]-Reboxetine
NCT00038311
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
Sarcoma
P3
Completed120RCT, Double-blindPN-152,243)/PN-196,444
NCT00856544
A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications
Arthritis, Rheumatoid
P3
Completed795RCT, Double-blindCP-690,550, CP-690,550, Placebo, Placebo
NCT01229436
Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex)
Dupuytren's Contracture
P3
Completed254Open-labelXiapex
NCT01120028
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Kidney Transplantation
P2P3
Completed852RCT, Open-labelAlemtuzumab, Basiliximab, Sirolimus, Tacrolimus
NCT01345630
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1
HIV-1
P3
Terminated813RCT, Double-blindMaraviroc, Emtricitabine/tenofovir, darunavir/ritonavir 800/100 mg, placebo for emtricitabine/tenofovir, placebo for maraviroc
NCT01808092
A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia
Nosocomial Pneumonia (NP), Ventilator-associated Pneumonia (VAP)
P3
Completed969RCT, Double-blindceftazidim-avibactam (CAZ-AVI, experimental product), meropenem (active comparator)
NCT01634139
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
Asthma
P3
Completed403RCT, Double-blindTiotropium low dose QD, Tiotropium high dose QD, Placebo
NCT00134264
A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease
Coronary Disease, Diabetes Mellitus
P3
Terminated15,067RCT, Double-blindtorcetrapib/atorvastatin, atorvastatin
NCT01127893
Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis
Osteoarthritis
P3
Terminated1RCT, Double-blindTanezumab, Tanezumab, Tanezumab
NCT00150436
To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.
Neuralgia
P3
Completed276Open-labelPregabalin
NCT00651300
A Study of the Recovery Benefits After Treatment With Parecoxib/Valdecoxib in Patients Undergoing Abdominal Surgery
Pain
P3
Terminated91RCT, Double-blindParecoxib/Valdecoxib, Placebo
NCT00920816
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Kidney Neoplasms
P3
Completed492RCT, Open-labelAxitinib (AG-013736), Sorafenib
NCT05011513
Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).
COVID-19
P2P3
Terminated1,440RCT, Double-blindPF-07321332, Ritonavir, Placebo, Placebo
NCT00373113
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine
Breast Neoplasms
P3
Terminated482RCT, Open-labelCapecitabine, Sunitinib malate
NCT00137410
Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee
Osteoarthritis,Knee
P3
Completed200RCT, Double-blindCelebrex
NCT00007735
Antibiotic Treatment of Gulf War Veterans' Illnesses
Persian Gulf Syndrome, Mycoplasma Infections
P3
Completed450RCT, Double-blindDoxycycline (200mg/day) or Placebo
NCT00743652
Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.
Pneumococcal Disease, 13-valent Pneumococcal Vaccine
P3
Completed373Open-label13-valent Pneumococcal Conjugate Vaccine, 13-valent Pneumococcal Conjugate Vaccine, 13-valent Pneumococcal Conjugate Vaccine, 13-valent Pneumococcal Conjugate Vaccine, 13-valent Pneumococcal Conjugate Vaccine
NCT00963235
Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS
HIV Infections, Pneumococcal Infections
P3
Completed331Open-label13-valent pneumococcal conjugate vaccine
NCT00075218
A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)
Gastrointestinal Stromal Tumor
P3
Completed361RCT, Double-blindPlacebo, SU011248
NCT00266851
AZMATICS: AZithroMycin/Asthma Trial In Community Settings
Asthma
P3
Completed97RCT, Double-blindAzithromycin, Placebo
NCT00300378
Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder
Depressive Disorder, Major
P3
Completed480RCT, Double-blinddesvenlafaxine 50 mg, desvenlafaxine 100 mg
NCT00643136
A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures
Sleep Deprivation, Epilepsies, Partial
P3
Completed17RCT, Double-blindPregabalin, Placebo
NCT00141336
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
Seizure Disorder, Partial
P3
Completed750Open-labelPregabalin
NCT00137371
Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis
Atrophic Vaginitis, Atrophy
P3
Completed480RCT, Double-blindPVC (daily for 21 days, 7 days off), PVC (twice weekly)
NCT00141167
A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation
Smoking Cessation
P3
Completed250RCT, Double-blindvarenicline
NCT00321997
A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.
Age-Related Macular Degeneration
P2P3
Completed540RCT, Double-blindPegaptanib sodium
NCT01210443
Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients
Hypertension, Pulmonary
P3
Terminated2Open-labelSitaxentan
NCT01975376
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
Cardiovascular Disease
P3
Terminated16,784RCT, Double-blindbococizumab (PF-04950615), Placebo
NCT01942135
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
Metastatic Breast Cancer
P3
Completed521RCT, Double-blindPalbociclib, Fulvestrant, Placebo, Fulvestrant
NCT01058642
Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia
Postherpetic Neuralgia
P2
Terminated41RCT, Double-blindADL5747, Placebo, Pregabalin
NCT00425256
Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)
Sexual Arousal Disorder
P2
Completed—RCT, Double-blindBremelanotide
NCT02400567
Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women
Neoadjuvant Operable Breast Cancer
P2
Completed125RCT, Open-labelFluorouracile, Epirubicin, Cyclophosphamide, Letrozole, Palbociclib
NCT01062113
Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain
Pain
P2
Completed255RCT, Double-blindCelecoxib, Celecoxib, Placebo
NCT00636246
A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.
Depressive Disorder, Major
P2
Completed510RCT, Double-blindsertraline/[S,S]-reboxetine, sertraline/[S,S]-reboxetine, sertraline, sertraline, sertraline/[S,S]-reboxetine, Placebo, sertraline/[S,S]-reboxetine, [S,S]-reboxetine monotherapy
NCT01281917
Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma
Non-Hodgkins Lymphoma
P2
Completed40Open-labelVelcade, Temsirolimus
NCT04569032
A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression
Peripheral T-cell Lymphoma
P2
Completed82Open-labelbrentuximab vedotin, cyclophosphamide, doxorubicin, prednisone
NCT03054363
Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer
Breast Cancer
P1P2
Completed42RCT, Open-labelTucatinib in Combination with Palbociclib and Letrozole, Tucatinib in Combination with Palbociclib and Letrozole
NCT01547299
Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer
Prostate Cancer
P2
Completed52RCT, Open-labelEnzalutamide, Leuprolide, Dutasteride
NCT05574010
A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)
Celiac Disease
P1P2
Terminated128RCT, Double-blindCohort 1 in Part A, Cohort 2 in Part A, Group 2 in Part B and Part C, Group 3 in Part B and Part C, Group 4 in Part B and Part C
NCT01069861
Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)
PPHN, Persistent Pulmonary Hypertension of the Newborn
P2
Terminated4Open-labelsildanefil
NCT01379144
A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension
Primary Open Angle Glaucoma, Ocular Hypertension
P2
Completed282RCT, Double-blindlatanoprost 75 ug, latanoprost 100 ug, latanoprost 125 ug, latanoprost 50 ug
NCT00570128
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
Down Syndrome
P2
Completed129RCT, Double-blindDonepezil HCl, Placebo
NCT03628066
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
Breast Cancer
P2
Completed24Open-labelLetrozole, Palbociclib, Goserelin
NCT00746967
An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder
Sexual Dysfunctions, Psychological, Sexual Arousal Disorder
P2
Completed267Open-labelsildenafil
NCT02384382
A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)
Prostate Carcinoma Metastatic to the Bone, Castration Resistant Prostate Cancer
P2
Completed23Open-labelEnzalutamide
NCT00143429
Corneal Versus Conjunctival Delivery Using a Delivery Device
Glaucoma, Open-Angle, Ocular Hypertension
P2
Withdrawn—RCT, Single-blindXalatan
NCT00483262
Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma
Multiple Myeloma
P1P2
Completed63Open-labelCCI-779, Bortezomib
NCT02921919
Open-Label Extension and Safety Study of Talazoparib
Cancer
P2
Completed120Open-labelTalazoparib
NCT05471492
Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease
Crohn Disease
P2
Withdrawn—RCT, Double-blindInvestigational Product, Placebo
NCT00006399
Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease
Alzheimer Disease
P2
Completed45Double-blindDonepezil, Estrogen, Progesterone
NCT03409458
A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab
Non-Small Cell Lung Cancer (NSCLC)
P1P2
Completed68Open-labelPT-112, avelumab
NCT00640458
Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder
Female Sexual Arousal Disorder
P2
Completed20RCT, Double-blindSildenafil 100 mg, Placebo
NCT04824937
Telaglenastat + Talazoparib In Prostate Cancer
Prostate Cancer Metastatic
P2
Withdrawn—Open-labelTelaglenastat, Talazoparib
NCT00993148
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
HIV-1 Infection, HIV Infections
P2
Completed25Open-labelmaraviroc, darunavir, ritonavir
NCT01889238
Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer
Advanced, Androgen Receptor Positive Triple Negative Breast Cancer
P2
Completed118Open-labelEnzalutamide
NCT01030406
Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users
Opioid Abuse
P2
Completed49RCT, Double-blind40/0mg taken first, 80/0mg taken first, 40/240mg taken first, 80/480mg taken first, 0/0mg taken first
NCT00640146
Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures
Opioid-induced Constipation
P2
Completed37RCT, Double-blindMethylnaltrexone bromide, Placebo
NCT06125522
TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)
Breast Cancer
P1P2
Terminated11Open-labelvepdegestrant, Samuraciclib
NCT00548717
Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation
Graft-vs-Host Disease
P2
Terminated15Open-labelSirolimus, Mycophenolate mofetil, Bortezomib
NCT00354978
Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients
Colorectal Cancer
P2
Completed49Open-label5-Fluorouracil, Bevacizumab, Leucovorin, Irinotecan
NCT01284920
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients
Prostate Cancer, Prostate Neoplasms
P1P2
Completed47Open-labelMDV3100
NCT02124668
A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Castration-Resistant Prostate Cancer, Prostate Cancer
P2
Completed30Open-labelEnzalutamide
NCT00437281
Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures
Epilepsies, Partial
P1P2
Completed65RCT, Double-blindPlacebo, Pregabalin
NCT04849364
Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer
Breast Cancer, Triple Negative Breast Cancer
P2
Terminated52Open-labelCapecitabine, Talazoparib, Pembrolizumab, Inavolisib
NCT04072952
A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Participants With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
Breast Cancer
P1P2
Completed219Open-labelVepdegestrant, Vepdegestrant, Palbociclib
NCT02841267
A Trial of PF-06252616 in Ambulatory Participants With LGMD2I
LGMD2I
P1P2
Completed19Open-labelPF 06252616
NCT06001177
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Celiac Disease, Coeliac Disease
P2
Completed55RCT, Double-blindKAN-101, Placebo
NCT00650611
A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders
Schizophrenia, Bipolar Disorder
P2
Completed63RCT, Open-labelZiprasidone, Ziprasidone
NCT04690855
A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer
Breast Cancer, Triple Negative Breast Cancer
P2
Terminated1Open-labelTalazoparib, Atezolizumab
NCT02528643
A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
P2
Completed165RCT, Double-blindEnzalutamide, Placebo
NCT00245609
Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure
Dental Anxiety
P2
Completed90RCT, Double-blindPregabalin, Alprazolam, Placebo
NCT01288911
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Prostatic Neoplasms
P2
Completed375RCT, Double-blindenzalutamide, bicalutamide
NCT05007821
Linezolid Dosing Strategies in Drug-Resistant TB
Tuberculosis, Multidrug-Resistant, Tuberculosis
P2
Completed138RCT, Open-labelLinezolid 600 mg, Linezolid 1200 mg (QD), Linezolid 1200 mg (TIW), Bedaquiline 200 mg, Bedaquiline 100 mg, Delamanid 300 mg, Clofazimine 300 mg, Clofazimine 100 mg
NCT02007512
Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Breast Cancer
P2
Completed247RCT, Double-blindEnzalutamide, exemestane, Placebo (for enzalutamide), exemestane
NCT00141310
Sildenafil Citrate for the Treatment of Established Pre-Eclampsia
Pre-eclampsia
P2
Terminated76RCT, Double-blindSildenafil citrate
NCT01091103
Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide
Metastatic Progressive Castration-resistant Prostate Cancer
P2
Completed60Open-labelEnzalutamide
NCT02296801
A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
Breast Cancer, Breast Carcinoma
P2
Completed307RCT, Open-labelLetrozole, palbociclib
NCT00634933
Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis
Arthritis, Rheumatoid
P2
Terminated222RCT, Double-blindTRU-015, Methylprednisolone, Prednisone, TRU-015, Methylprednisolone, Prednisone, TRU-015, Methylprednisolone, Prednisone
NCT01650194
A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients
Metastatic Castration-Resistant Prostate Cancer
P2
Completed60Open-labelenzalutamide, abiraterone acetate, prednisone
NCT00675025
Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial
Down Syndrome
P2
Terminated117Open-labelDonepezil hydrochloride (Aricept)
NCT01534052
A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100
Castration-Resistant Prostate Cancer (CRPC)
P2
Completed52Open-labelEnzalutamide
NCT01360671
IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn
Persistent Pulmonary Hypertension of the Newborn
P2
Withdrawn—Open-labelSildenafil
NCT07782450
A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases
Systemic Lupus Erythematosus, Rheumatoid Arthritis
P1P2
Not Yet Recruiting54Open-labelPF-08154225
NCT01122680
Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma
Asthma
P2
Completed105RCT, Double-blindTiotropium bromide, tiotropium bromide, tiotropium bromide, Placebo
NCT00037180
For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy
Neoplasm Metastasis, Colorectal Neoplasms
P2
Terminated212RCT, Double-blindCelecoxib, Irinotecan, 5-fluorouracil, Leucovorin
NCT00559910
A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).
Chronic Obstructive Pulmonary Disease
P2
Completed230RCT, Double-blindPH-797804, Placebo
NCT03472560
A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
Non-Small Cell Lung Cancer, Urothelial Cancer
P2
Terminated61Open-labelAvelumab (MSB0010718C), Axitinib (AG-013736)
NCT00205803
Study Evaluating Pneumococcal Vaccine in Healthy Infants
Healthy Subjects, Pneumococcal Infections
P1P2
Completed249RCT, Double-blind13-Valent Pneumococcal Conjugate Vaccine (13vPnC), 7-Valent Pneumococcal Conjugate Vaccine (7vPnC)
NCT01693822
A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy
Clear-cell Metastatic Renal Cell Carcinoma
P2
Completed65Open-labelAxitinib
NCT02255227
Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD
Infections, Pneumococcal, Bowel Diseases, Inflammatory
P2
Terminated104RCT, Open-labelPrevenar 13, Pneumo 23
NCT00004861
Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
Pancreatic Cancer
P2
Completed—RCTgemcitabine hydrochloride, tacedinaline
NCT00323986
Azithromycin Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and Tracheostomy
COPD, Tracheostomy
P2
Terminated30RCT, Open-labelazithromycin (drug)
NCT03258502
A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection
Respiratory Syncytial Virus Infections
P2
Completed66RCT, Double-blindRV521, Placebo
NCT01517373
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
Diabetes Mellitus, Type 2
P2
Completed304RCT, Double-blindPlacebo, PF-04937319 10 mg, PF-04937319 50 mg, PF-04937319 100 mg, Glimepiride
NCT00192166
Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months
Influenza
P2
Completed1,200RCT, Double-blindCAIV-T
NCT00959946
Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer
Advanced Breast Cancer (Parts 1 and 2), Advanced Pancreatic Cancer (Part 1)
P1P2
Terminated32Open-labelBosutinib, Capecitabine
NCT06821061
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
Influenza, COVID-19 (Coronavirus Disease 2019)
P1P2
Completed2,650RCT, Double-blindInvestigational Influenza Vaccine, Investigational COVID-19 Vaccine, Licensed Influenza Vaccine 1, Licensed Influenza Vaccine 2, Licensed Influenza Vaccine 3, Licensed COVID-19 Vaccine
NCT04766086
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women
Group B Streptococcus Infections
P2
Completed306RCT, Double-blindMultivalent Group B streptococcus vaccine, Tetanus, diphtheria, and acellular pertussis vaccine, Placebo
NCT00930059
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
Alzheimer's Disease
P2
Completed191RCT, Double-blindPF-04447943, Placebo
NCT00615056
A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen
Colorectal Neoplasms
P2
Completed171RCT, Open-labelBevacizumab (avastin), FOLFIRI (Irinotecan, leucovorin, 5-fluorouracil [5FU]), AG-013736 (axitinib), FOLFOX (oxaliplatin, leucovorin, 5-fluorouracil [5FU]), AG-013736 (axitinib), FOLFIRI (irinotecan, leucovorin, 5-fluorouracil [5FU]), Bevacizumab (avastin), FOLFOX (oxaliplatin, leucovorin, 5-fluorouracil [5FU])
NCT00553254
Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer
Carcinoma, Non Small Cell Lung
P2
Completed55Open-labelPF-00299804
NCT01927341
Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors
Metastatic Colorectal Cancer
P1P2
Completed53Open-labelMEK162, Panitumumab
NCT01393639
Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis
Rheumatoid Arthritis
P2
Completed323RCT, Double-blindPF-04171327, PF-04171327, PF-04171327, PF-04171327, prednisone
NCT00696787
A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia
Fibromyalgia
P2
Terminated125RCT, Double-blindDesvenlafaxine Sustained Release (DVS SR), Lyrica® (Pregabalin), Placebo
NCT00482664
The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder.
Sexual Dysfunction, Physiological
P2
Completed84RCT, Double-blindCP-866,087, CP-866,087, CP-866,087, Placebo
NCT00479492
Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers
Obesity
P2
Completed94RCT, Double-blindCP-866,087, CP-866,087, CP-866,087, placebo
NCT01211275
Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma
Malignant Pleural Mesothelioma
P1P2
Completed32RCT, Open-labelaxitinib, chemotherapy
NCT00037219
The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.
Candidiasis
P2
Completed120Open-labelAnidulafungin, VER002
NCT00823979
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
HIV-1
P2
Terminated105RCT, Double-blindUK-453,061 Dose 1, UK-453,061 Dose 2, Etravirine
NCT01649180
NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Renal Cell Carcinoma
P2
Terminated3Open-labelAxitinib
NCT00606008
A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
Anaplastic Astrocytoma, Glioblastoma
P2
Completed30Open-labelSunitinib Malate
NCT04225897
A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.
Respiratory Syncytial Virus (RSV), Lower Resp Tract Infection
P2
Terminated51RCT, Double-blindRV521, Placebo
NCT05038982
Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin
Prurigo Nodularis, Pruritus
P2
Completed20Open-labelAbrocitinib
NCT02055976
Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects
Hypercholesterolemia
P2
Completed218RCT, Double-blindBococizumab (PF-04950615;RN316), Bococizumab (PF-04950615;RN316), Bococizumab (PF-04950615;RN316), Placebo, Ezetimibe, Bococizumab (PF-04950615;RN316), Bococizumab (PF-04950615;RN316), Bococizumab (PF-04950615;RN316), Placebo
NCT01331291
Bosutinib in Adult Patients With Recurrent Glioblastoma
Glioblastoma
P2
Completed36Open-labelbosutinib
NCT03693170
Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer
BRAF V600E-mutant Metastatic Colorectal Cancer
P2
Completed95Open-labelencorafenib, Binimetinib, Cetuximab
NCT03530696
T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
P2
Completed55RCT, Open-labelPalbociclib, T-DM1
NCT00550446
A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis
Arthritis, Rheumatoid
P2
Completed386RCT, Double-blindAdalimumab, CP-690-550, CP-690-550, CP-690-550, CP-690,550, CP-690,550, Placebo
NCT01246583
CP-690-550 Ointment For Chronic Plaque Psoriasis
Psoriasis
P2
Completed71RCT, Double-blindCP-690,550 Ointment 1, Vehicle 1, CP-690,550 Ointment 2, Vehicle 2
NCT00830427
A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects
Asthma, Bronchial, Lung Diseases, Obstructive
P2
Withdrawn—RCT, Single-blindPF-00610355, PF - 00610355, PF - 00610355
NCT07672782
Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva
Vulvar Carcinoma, Recurrent or Metastatic Vulvar Cancer
P2
Not Yet Recruiting28Open-labelTisotumab Vedotin
NCT01096667
Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)
Diabetes Mellitus, Type 2, Hypertension
P2
Completed194RCT, Double-blindPlacebo to Ertuglilflozin 1 or 5 mg, Ertugliflozin 1 mg, Ertugliflozin 5 mg, Ertugliflozin 25 mg, HCTZ 12.5mg, Placebo to HCTZ, Placebo to ertuglilflozin 25 mg
NCT02109445
Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies
Metastatic Cancer Pancreas
P2
Terminated3RCT, Open-labelPF-03084014, Gemcitabine, Nab-paclitaxel, PF-03084014, Gemcitabine, Nab-paclitaxel, Gemcitabine, Nab-paclitaxel
NCT00569972
A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia
Insomnia
P2
Completed682RCT, Double-blindPD 0200390, PD 0200390, PD 0200390, PD 0200390, Placebo
NCT00895895
Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease
Alzheimer Disease
P2
Terminated526RCT, Double-blindPlacebo, SAM-531 1.5 mg, SAM-531 3.0 mg, SAM-531 5.0 mg, Donepezil
NCT00961571
Sunitinib and Capecitabine for First Line Colon Cancer
Metastatic Colorectal Cancer
P2
Terminated50Open-labelsunitinib and capecitabine
NCT00652028
Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects
Intubated and Mechanically Ventilated Pediatric Subjects
P2
Completed69Open-labelDexmedetomidine, midazolam; fentanyl
NCT00752557
Study Evaluating Changes In Bone Mineral Density (BMD), And Safety Of Rhbmp-2/CPM In Subjects With Decreased BMD
Osteoporosis
P2
Completed50RCT, Double-blindrhBMP-2/CPM injection and bisphosphonates, calcium, and vitamin D (oral bisphosphonate therapy), rhBMP-2/CPM injection and bisphosphonates, calcium, and vitamin D (oral bisphosphonate therapy), bisphosphonates, calcium, and vitamin D
NCT04785612
Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults
Respiratory Syncytial Virus Infections
P2
Completed70RCT, Double-blindRSVPreF
NCT03400254
Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER")
Breast Cancer
P1P2
Withdrawn—RCT, Single-blindHydroxychloroquine (HCQ), Gedatolisib
NCT01087203
A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathy
P2
Terminated73RCT, Double-blindTanezumab, placebo
NCT03341845
Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC
Renal Cell Carcinoma
P2
Unknown40Open-labelAxitinib, Avelumab
NCT05070845
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
Primary Immune Thrombocytopenia
P2
Terminated61Open-labelPF-06835375
NCT00062751
Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms
Breast Neoplasms
P2
Completed108RCT, Open-labelLetrozole / Temsirolimus (CCI-779), Letrozole / Temsirolimus (CCI-779), Letrozole
NCT01730339
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
Reduction of Hypertrophic Skin Scarring
P2
Completed103RCT, Double-blindPF-06473871, PF-06473871
NCT00265317
A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone
Carcinoma, Non-Small-Cell Lung
P2
Completed162RCT, Double-blinderlotinib, sunitinib, erlotinib, placebo
NCT00787202
A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.
Ulcerative Colitis
P2
Completed195RCT, Double-blindCP- 690 550, CP- 690 550, CP- 690 550, CP- 690 550
NCT03895372
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
Psoriasis
P2
Completed179RCT, Double-blindPF-06826647 or Placebo, PF-06826647
NCT01059825
Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)
Diabetes Mellitus, Type 2
P2
Completed375RCT, Double-blindPlacebo to Ertugliflozin, Ertugliflozin 1 mg, Ertugliflozin 5 mg, Ertugliflozin 25 mg, Sitagliptin 100 mg, Placebo to Sitagliptin, Metformin
NCT00916617
Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab
Alzheimer Disease
P2
Terminated62Open-labelbapineuzumab
NCT03769194
Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.
Lyme Borreliosis
P2
Completed572RCT, Double-blindVLA15, Placebo
NCT00615199
A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease
Crohn's Disease
P2
Completed139RCT, Double-blindCP-690,550, CP-690,550, CP-690,550, Placebo
NCT04321031
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis With Liver Fibrosis
P2
Completed256RCT, Double-blindPlacebo, PF-06865571, PF-05221304
NCT06897202
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM
Obesity in Diabetes, Type 2 Diabetes Mellitus (T2DM)
P2
Completed133RCT, Double-blindMET097 Injection, Placebo
NCT01577381
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Age-Related Maculopathy
P2
Terminated10RCT, Double-blindRN6G, Placebo
NCT00678782
Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis
Persistent Knee Joint Synovitis
P2
Completed31RCT, Single-blindetanercept, placebo
NCT00496223
A Phase I/II Study of Sunitinib and Dacarbazine
Melanoma
P1P2
Terminated11Open-labelSunitinib, Dacarbazine
NCT00589784
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
CNS Cancer, Meningioma
P2
Completed50Open-labelSunitinib
NCT01227434
A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
Glioblastoma, Gliosarcoma
P2
Terminated23Open-labelPD 0332991 (pre-surgery), PD 0332991
NCT03407430
Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain
Breast Cancer, Lymphoma
P2
Terminated11RCT, Double-blindPregabalin, Placebo
NCT00676429
Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders
Conduct Disorder, Oppositional Defiant Disorder
P2
Completed51RCT, Double-blindZiprasidone Hydrochloride, Placebo
NCT00269672
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects
Vaccines, Pneumococcal Conjugate Vaccine
P2
Completed915RCT, Open-label13-valent Pneumococcal Conjugate Vaccine
NCT00835900
An Alternative Dosing Schedule of Varenicline for Smoking Cessation
Smoking Cessation
P2
Completed60RCT, Double-blindvarenicline, placebo
NCT00707239
Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia
Pneumonia, Bacterial
P2
Terminated108RCT, Double-blindtigecycline, tigecycline, imipenem/cilastatin
NCT06279195
Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment
Pelvic Pain
P2
Withdrawn—Open-labelRelugolix (40 mg) /estradiol (1 mg)/norethisterone acetate (0.5 mg) oral tablet
NCT02040857
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer
Breast Cancer
P2
Completed162Open-labelPalbociclib, Aromatase Inhibitor
NCT00387660
Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer
Lung Cancer
P2
Completed80Open-labelcarboplatin, irinotecan
NCT01212718
Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase
Colorectal Cancer, Non Resectable Metastasis
P2
Completed168RCT, Double-blindFUFA, systemic chemotherapy
NCT00163085
The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease
Parkinson's Disease
P2
Completed12RCT, Double-blindNR2B NMDA Antagonist CP-101,606 (traxoprodil)
NCT01038297
Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty
Scar Prevention
P2
Completed30RCT, Double-blindEXC 001, Placebo
NCT00919035
Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients
Prostate Cancer
P2
Completed21Open-labeltorisel
NCT00662025
Study Of Sunitinib With Capecitabine In Breast Cancer
Advanced/Metastatic Breast Cancer
P2
Completed63Open-labelCapecitabine, Sunitinib
NCT00031278
Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer
Carcinoma, Metastatic Breast
P1P2
Completed12Open-labelCPG 7909, Herceptin®, CPG 7909, Herceptin®, CPG 7909, Herceptin®, CPG 7909, Herceptin®
NCT00355576
Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
P2
Completed86RCT, Double-blindCelecoxib, Creatine, Minocycline
NCT02215252
A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)
Diabetic Neuropathy, Painful
P2
Completed141RCT, Double-blindPF-05089771 150 mg, Matched placebo for PF-05089771 150 mg and pregabalin 300 mg, Pregabalin 300 mg, PF-05089771 150 mg + Pregabalin 300 mg
NCT02205476
A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study
Hypertrophic Scars Resulting From Prior Breast Scar Revision Surgery
P2
Terminated10Open-labelPF-06473871, PF-06473871
NCT00353808
A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain.
Pain
P2
Terminated112Open-label[S,S]-Reboxetine
NCT00949325
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
Sarcoma
P1P2
Completed24Open-labeltemsirolimus plus liposomal doxorubicin
NCT00614705
PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia
Neuralgia, Postherpetic
P2
Completed80RCT, Double-blindPH-797804, Placebo
NCT00143091
Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder
Depressive Disorder, Major
P2
Terminated200RCT, Double-blindCP-316,311, Placebo, Sertraline
NCT01592240
Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin
Hypercholesterolemia
P2
Completed354RCT, Double-blindPBO, 200mg PF-04950615 (RN316), 300mg PF-04950615 (RN316), PBO, PF-04950615, PF-04950615, PF-04950615
NCT00510718
A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer
Prostate Cancer, Hormone Refractory Prostate Cancer
P1
Completed140Open-labelMDV3100
NCT01254396
Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.
Erectile Dysfunction
P1
Completed12RCT, Open-labelSildenafil, Sildenafil
NCT00581789
Erlotinib and Sunitinib in NSCLC
Non Small Cell Lung Cancer
P1
Completed11Open-labelerlotinib, sunitinib
NCT05652660
A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults
Healthy
P1
Completed12Open-labelARV-471, Rosuvastatin
NCT06005688
A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants
Healthy Participants
P1
Completed12Open-labelVepdegestrant, Carbamazepine
NCT01256151
Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet
Anxiety Disorder
P1
Completed28RCT, Open-labelAlprazolam tablet, Alprazolam sublingual
NCT00987779
Bioequivalence Study Of Gabapentin Between Tablet And Liquid Formulation And The Food Effect Study Of Liquid Formulation
Healthy
P1
Completed26RCT, Open-labelGabapentin, Gabapentin
NCT01046162
A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions
Healthy
P1
Withdrawn—RCT, Open-labelAlprazolam, Alprazolam
NCT01285505
Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation
Healthy
P1
Withdrawn—RCT, Open-labelalprazolam commercial sublingual formulation, alprazolam test sublingual tablet
NCT06466187
A Study of SGN-MesoC2 in Advanced Solid Tumors
Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms
P1
Terminated19Open-labelPF-08052666
NCT00800592
Sildenafil IV Bolus Study
Hypertension, Pulmonary
P1
Completed12Open-labelsildenafil
NCT01330472
An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites
Healthy Subjects
P1
Completed16RCT, Open-labelXanax XR tablets 3 mg (sourced from Caugus), Xanax XR tablets 3 mg (sourced from Barceloneta)
NCT06120504
A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers
Lymphoma, T-Cell, Cutaneous, Hodgkin Disease
P1
Terminated22Open-labelPF-08046045
NCT00739999
8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial Hypercholesterolemia
Pediatric Heterozygous Hypercholesterolemia
P1
Completed39Open-labelAtorvastatin, Atorvastatin
NCT04134884
Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer
Metastatic Breast Cancer, Triple Negative Breast Cancer
P1
Completed34Open-labelTalazoparib, ASTX727
NCT05930925
A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy Adults
Healthy
P1
Completed12RCT, Open-label[phenyl-14C]ARV-471, [oxoisoindolin-14C]ARV-471
NCT01389609
Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition
Hypertension
P1
Completed24RCT, Open-labelDoxazosin 4 mg Japanese marketed IR tablet, Doxazosin 4 mg ODT with water, Doxazosin 4 mg ODT without water
NCT00925106
Pharmacokinetics Of Celecoxib Test Formulations
Healthy Volunteers
P1
Completed16RCT, Open-labelCelebrex capsule, Test formulation D1, Test formulation D2, Test formulation D3
NCT06254495
A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers
Hodgkin Disease, Lymphoma, T-Cell, Peripheral
P1
Terminated58Open-labelPF-08046044/SGN-35C
NCT00638742
A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.
Glaucoma, Ocular Hypertension
P1
Completed47Open-labellatanoprost
NCT00813241
A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers
Healthy Volunteers
P1
Completed16RCT, Open-labelcelecoxib reference formulation, celecoxib test formulation A1, celecoxib test formulation B2, celecoxib test formulation C1
NCT02637193
A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects
Healthy Subjects
P1
Completed54RCT, Double-blindVenlafaxine, Moxifloxacin, Drug - placebo
NCT01235195
A Study Comparing the Drug Exposure in Humans After Administration of a 50 mg Tablet of Sertraline Hydrochloride as Compared to a 50 mg Capsule of Sertraline Hydrochloride Under Fasted (Nonfed) Conditions
Healthy
P1
Completed30RCT, Open-labelsertraline hydrochloride, sertraline hydrochloride
NCT06275841
A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant
Healthy
P1
Completed12Open-labelvepdegestrant, esomeprazole
NCT01004614
Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet
Healthy
P1
Completed48RCT, Open-labelAmlodipine, Amlodipine, Amlodipine, Amlodipine
NCT01027117
A Relative Bioavailability Study of Revatio for the Crushed Tablets, Extemporaneously Prepared Formulation, and the Intact Tablets at 20 mg Dose in Healthy Volunteers
Healthy
P1
Completed18RCT, Open-labelRevatio, Revatio, Revatio
NCT00990223
Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity
Healthy Volunteers
P1
Completed20RCT, Double-blindEplerenone or Placebo
NCT01737203
Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil
Healthy
P1
Completed53RCT, Open-labelViagra, sildenafil ODT, sildenafil ODT
NCT01565928
Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer
Prostate Cancer
P1
Completed23Open-labelMDV3100
NCT02997176
An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)
Advanced Solid Tumors
P1
Completed38Open-labelTalazoparib
NCT02207504
Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer
Castration-resistant Prostate Cancer
P1
Completed24Open-labelCrizotinib, Enzalutamide
NCT00950404
Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral Tablet
Healthy Volunteers
P1
Completed16RCT, Open-labelViagra 50 mg tablet, Formulation B ODT tablet 50 mg, Formulation C ODT tablet 50 mg, Formulation D ODT tablet 50 mg
NCT01443169
A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered Fasted
Healthy
P1
Completed16RCT, Open-labelSequence 1 - Treatment A: Controlled Release Pregabalin, Sequence 1 - Treatment B: Controlled Release Pregabalin, Sequence 1 - Treatment C:Controlled Release Pregabalin, Sequence 1 - Treatment D: Controlled Release Pregabalin, Sequence 1 - Treatment E: Immediate Release Pregabalin, Sequence 2 - Treatment B: Controlled Release Pregabalin, Sequence 2 - Treatment D: Controlled Release Pregabalin, Sequence 2 - Treatment A: Controlled Release Pregabalin, Sequence 2 - Treatment C: Controlled Release Pregabalin, Sequence 2 - Treatment E: Immediate Release Pregabalin, Sequence 3 - Treatment C: Controlled Release Pregabalin, Sequence 3 - Treatment A: Controlled Release Pregabalin, Sequence 3 - Treatment D: Controlled Release Pregabalin, Sequence 3 - Treatment B: Controlled Release Pregabalin, Sequence 3 - Treatment E: Immediate Release Pregabalin, Sequence 4 - Treatment D: Controlled Release Pregabalin, Sequence 4 - Treatment C: Controlled Release Pregabalin, Sequence 4 - Treatment B: Controlled Release Pregabalin, Sequence 4 - Treatment A: Controlled Release Pregabalin, Sequence 4 - Treatment E: Immediate Release Pregabalin
NCT00827034
A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects
Alzheimer's Disease, Huntington's Disease
P1
Completed14RCT, Open-labelWarfarin, Dimebon, Warfarin
NCT01291524
Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted At Bedtime Or Immediately Following A 400-500 or 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers
Healthy
P1
Completed24RCT, Open-labelPregabalin controlled release, 330 mg, 400 to 500 calorie, Pregabalin controlled release, 330 mg, 600- 750 calorie, Pregabalin controlled release, 330 mg, bedtime, Pregabalin immediate release, 300 mg
NCT01342198
An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release Tablet
Healthy
P1
Completed18RCT, Open-labelPregabalin controlled release, 330 mg, Pregabalin controlled release, 330 mg, erythromycin
NCT04391868
A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form
Healthy
P1
Withdrawn—RCT, Open-labelViagra Tablet, Sildenafil Citrate ODF, Sildenafil Citrate ODF
NCT01177293
Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate Capsules
Healthy Volunteers
P1
Completed14RCT, Open-labelAmlodipine - reference, Amlodipine ODT - test
NCT01008527
Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100
Melanoma
P1
Completed22Open-labelCP 870,893, Peptides, Oncovir poly IC:LC
NCT01423123
Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
Breast Cancer
P1
Completed21Open-labelPaclitaxel, trastuzumab, Neratinib
NCT00760474
An fMRI Study Of Brain Response In Patients With Fibromyalgia
Fibromyalgia
P1
Completed27RCT, Double-blindPregabalin, then placebo, Placebo, then pregabalin
NCT01355068
A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia
Healthy
P1
Completed26RCT, Open-labelEpanutin Infatabs (Phenytoin), Dilantin Infatabs (Phenytoin)
NCT00758004
Bioequivalence Study Of Pediatric Appropriate Formulation
Hypercholesterolemia
P1
Completed76RCT, Open-labelAtorvastatin, Atorvastatin pediatric appropriate formulation
NCT00877955
Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation
Healthy
P1
Withdrawn—RCT, Open-labelalprazolam sublingual tablet commercial, alprazolam sublingual tablet test
NCT00866463
A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects
Erectile Dysfunction
P1
Completed18RCT, Open-labelSildenafil, Sildenafil, Sildenafil
NCT00975481
A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users
Alzheimer's Disease, Huntington's Disease
P1
Completed36RCT, Double-blinddimebon, dimebon, dimebon, placebo, alprazolam, alprazolam
NCT00821444
Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules
Healthy
P1
Completed11RCT, Open-labelziprasidone, B16 Fasted, B16 Fed
NCT00795938
Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects.
Erectile Dysfunction
P1
Completed18RCT, Open-labelSildenafil, Sildenafil, Sildenafil
NCT01202422
An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule
Healthy
P1
Completed24RCT, Open-labelPregabalin controlled release, 165 mg, Pregabalin controlled release, 330 mg, Pregabalin immediate release, 150 mg
NCT01693445
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer
Gastrointestinal Neoplasms
P1
Completed22Open-labelOIS (Oxaliplatin, Irinotecan, S-1)
NCT00990613
A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin
Alzheimer's Disease, Huntington's Disease
P1
Completed19RCT, Double-blindDimebon IR, Dimebon Transdermal, Dimebon Transdermal, Dimebon IR, Dimebon Transdermal
NCT01597193
Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
Breast Cancer
P1
Completed101Open-labelenzalutamide, anastrozole, exemestane, fulvestrant, enzalutamide, exemestane
NCT00831532
Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function
Hepatic Failure
P1
Completed23Open-labelDimebon, Dimebon, Dimebon, Dimebon
NCT00720148
A Phase I Trial of Bortezomib and Sunitinib
Solid Tumors
P1
Completed30Open-labelSunitinib and Bortezomib
NCT01257529
An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers
Healthy
P1
Completed28RCT, Open-labelPregabalin controlled release, 330 mg, low-fat, Pregabalin controlled release, 330 mg, medium-fat, Pregabalin controlled release, 330 mg, high-fat, Pregabalin immediate release, 300 mg
NCT00907322
A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults
Healthy Volunteers
P1
Completed12RCT, Double-blindDimebon, Dimebon, Dimebon, Dimebon
NCT04176367
An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese Participants
Pharmacokinetics
P1
Completed40RCT, Open-labelNicergoline from China, Nicergoline from Italy
NCT00481728
Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.
Overactive Bladder
P1
Completed28RCT, Double-blindTolterodine
NCT01286987
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Advanced or Recurrent Solid Tumors, Breast Neoplasms
P1
Completed113Open-labelTalazoparib
NCT00931073
A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers
Alzheimer's Disease, Huntington's Disease
P1
Completed24Open-labelDimebon alone, Dimebon + Ketoconazole, Dimebon + Omeprazole
NCT04703920
Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer
Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer
P1
Completed26Open-labelTalazoparib, Belinostat
NCT02651623
Study to Evaluate The Effect Of Sertraline on the Cardiac Repolarization in Healthy Subjects
Healthy
P1
Completed54RCT, Double-blindSertraline, Moxifloxacin, Drug - Placebo
NCT00860119
Bioequivalence of Alprazolam Sublingual vs Oral Tablets
Healthy
P1
Completed23RCT, Open-labelalprazolam sublingual tablet, alprazolam oral tablet
NCT00904748
A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate
Erectile Dysfunction
P1
Completed47RCT, Open-labelsildenafil citrate 100 mg CT, sildenafil citrate 100 mg CT, Viagra®
NCT00777517
Bioequivalence Study On Pediatric Appropriate Formulation
Hypercholesterolemia
P1
Completed76RCT, Open-labelLipitor, Atorvastatin pediatric formulation
NCT03502681
A Study Combining Eribulin Mesylate With Avelumab in Cisplatin Ineligible Metastatic Urothelial Cell Cancer Patients
Metastatic Urothelial Cell Cancer
P1
Terminated6Open-labelEribulin Mesylate, Avelumab
NCT05571839
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Cutaneous Melanoma, Non-small Cell Lung Cancer
P1
Terminated41Open-labelPF-08046049
NCT00788047
A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan
Huntington Disease, Alzheimer Disease
P1
Completed14RCT, Open-labelDextromethorphan, Dimebon + Dextromethorphan
NCT00871806
Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With Water
Healthy Volunteers
P1
Completed20RCT, Open-labelCommercial tablet with water, ODT #1 without water, ODT #2 without water, ODT #1 with water, ODT #2 with water
NCT00824590
A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function
Alzheimer's Disease, Huntington's Disease
P1
Completed20Open-labelDimebon, Dimebon
NCT00998036
Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors
Triple Negative Breast Cancer
P1
Completed9Open-labelTemsirolimus, Cisplatin, Erlotinib
NCT02725112
Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers
Healthy
P1
Completed25RCT, Open-labelPregabalin ER, Pregabalin ER, Pregabalin ER, Pregabalin ER, Pregabalin ER, Pregabalin ER
NCT05501769
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
Breast Cancer
P1
Completed32Open-labelARV-471 in combination with Everolimus
NCT06347861
A Study to Learn How Various Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood of Healthy Adults
Healthy
P1
Completed52RCT, Open-labelsingle dose of vepdegestrant as tablet formulation (Treatment A), single dose of vepdegestrant as tablet formulation (Treatment B), single dose of vepdegestrant as tablet formulation (Treatment C)
NCT01111188
Trial of PD 0332991 Plus Bortezomib in Patients With Relapsed Mantle Cell Lymphoma
Mantle Cell Lymphoma
P1
Terminated20Open-labelPD 0332991, bortezomib
NCT04498520
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
P1
Withdrawn—Open-labelAbexinostat Tosylate, Fulvestrant, Palbociclib
NCT00506805
Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies
Cancer
P1
Completed44Open-labelSNX-5422
NCT05014139
A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
Urinary Bladder Neoplasms, Carcinoma in Situ
P1
Terminated37Open-labelEnfortumab vedotin
NCT01257516
An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers
Healthy
P1
Completed18RCT, Open-labelPregabalin immediate release, 300 mg, Pregabalin controlled release, 330 mg
NCT06645938
A Study to Learn How Different Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood in Healthy Adults
Healthy
P1
Completed12RCT, Open-labelsingle dose of vepdegestrant as tablet formulation (Treatment A), single dose of vepdegestrant as tablet formulation (Treatment B)
NCT01656798
Food Effect Study For New Formulation
Healthy
P1
Completed12RCT, Open-labelsildenafil citrate, sildenafil citrate
NCT06256510
A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam
Healthy Participants
P1
Completed15Open-labelMidazolam, Vepdegestrant
NCT01247805
A Pivotal Bioequivalence Study Between The Sildenafil Powder For Oral Suspension (10 Mg/Ml) And The Sildenafil 10 Mg Immediate Release (IR) Tablet Relative To The Revatio 20 Mg IR Tablet In Healthy Volunteers Under Fasting Conditions
Pulmonary Arterial Hypertention
P1
Completed42RCT, Open-labelsildenafil citrate, Sildenafil citrate, sildenafil citrate
NCT01027689
Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation
Healthy
P1
Withdrawn—RCT, Open-labelalprazolam commercial immediate release oral tablet, alprazolam test sublingual tablet
NCT01521767
Pharmacokinetics and Relative Bioavailability Study
Urinary Bladder, Overactive
P1
Completed16RCT, Open-labeltolterodine tartrate, tolterodine tartrate, tolterodine tartrate, tolterodine tartrate, tolterodine tartrate
NCT01270815
An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following Various Sized Lunches As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers
Healthy
P1
Completed28RCT, Open-labelPregabalin controlled release, 330 mg, 400 to 500 calories, Pregabalin controlled release, 330 mg, 600 to 750 calories, Pregabalin controlled release, 330 mg, 800 to 1000 calories, Pregabalin immediate release, 300 mg
NCT00831506
Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects
Alzheimer Disease, Huntington Disease
P1
Completed12RCT, Double-blinddigoxin, digoxin, dimebon
NCT01321671
Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers
Healthy
P1
Completed24RCT, Open-labelPregabalin controlled release, 330 mg, 600- 750 calorie, Pregabalin controlled release, 330 mg, fasted, Pregabalin immediate release, 300 mg
NCT03070548
A Study of Talazoparib in Patients With Advanced Solid Tumors
Advanced Solid Tumors
P1
Completed6Open-labelTalazoparib
NCT00825084
A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects
Alzheimer's Disease, Huntington's Disease
P1
Completed45RCT, Double-blindDimebon, Dimebon, Dimebon, Dimebon
NCT01399840
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
Acute Myeloid Leukemia, Myelodysplastic Syndrome
P1
Completed33Open-labelBMN 673
NCT01989143
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects.
Healthy
P1
Completed92RCT, Double-blindPF-06480605, Placebo, PF-06480605, Placebo, PF-06480605, Placebo
NCT06646042
A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy Adults
Healthy
P1
Completed12RCT, Open-labelibuzatrelvir, carbamazepine ER
NCT01065662
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
Endometrial Cancer, Ovarian Cancer
P1
Completed11Open-labeltemsirolimus, cediranib
NCT00440427
Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)
Depressive Disorder, Major
P1
Completed12RCT, Open-labelDesvenlafaxine Sustained Release (DVS SR)
NCT04604496
STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT
Hepatic Impairment, Healthy Volunteers
P1
Completed24Single-blindPF-06882961 20MG
NCT04171141
Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.
Gastrointestinal Tumors, Colorectal Adenocarcinomas
P1
Terminated79Open-labelPF-07062119, Anti-PD1, Anti-VEGF
NCT01044537
A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
P1
Completed50RCT, Double-blindPlacebo, PF-04937319
NCT00788294
Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously
Healthy Volunteers
P1
Completed76Open-labeltanezumab, tanezumab, tanezumab, tanezumab
NCT02316756
A Single Ascending Dose Study To Evaluate Safety And Pharmacokinetics Of Compound PF-06648671 In Healthy Subjects
Healthy Subjects
P1
Completed18RCT, Double-blindPF-06648671, Placebo
NCT02537002
Single Dose Study of PF-05230907 in Healthy Japanese Subjects
Healthy
P1
Completed17RCT, Double-blindPF-05230907, PF-05230907, Placebo
NCT05386472
A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19
COVID-19
P1
Terminated25Open-labelnirmatrelvir, ritonavir
NCT01092845
Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers
Healthy, Sleep
P1
Completed30RCT, Double-blindPF-04457845 / matched placebo, PF-04457845 / matched placebo
NCT02014272
A Bioequivalence Study Comparing A Fixed Dose Combination Formulation, Rin 150 And Individual Reference Drugs In Healthy Volunteers
Healthy Volunteers
P1
Completed28RCT, Open-labelRIN 150, reference drugs
NCT04124653
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy Participants
Healthy Participants
P1
Completed44RCT, Double-blindPF-06842874, Placebo, Relative Bioavailability
NCT02038777
A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies
Acute Myeloid Leukemia
P1
Completed48Open-labelPF-04449913, PF-04449913, Low dose ARA-C (LDAC), PF-04449913, Daunorubicin, Cytarabine, PF-04449913, Azacitidine, PF-04449913, LDAC
NCT03343054
A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors
Neoplasms, Breast Neoplasms
P1
Completed28Open-labeltalazoparib
NCT03448172
Single-dose Study of [14C]PF-05221304 Metabolism and Excretion in Healthy Adult Male Subjects
Healthy
P1
Completed6Open-label[14C]PF-05221304
NCT04621227
Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity
Obesity
P1
Completed16Open-labelPF-06882961, Rosuvastatin, Midazolam
NCT01184001
A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy Subjects
Rheumatoid Arthritis
P1
Completed16RCT, Open-labelTreatment A, Treatment B, Treatment B, Treatment A
NCT02097329
Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food
Healthy
P1
Completed27Open-labelpalbociclib commercial free base, famotidine, rabeprazole, palbociclib commercial free base, antacid, antacid
NCT00195312
Study Evaluating Vaccine in Adults With HIV
HIV Infections
P1
Terminated91RCT, Double-blindHIV-1 gag DNA (formulated with bupivacaine), IL-15 DNA (formulated with bupivacaine), IL-12 DNA (formulated with bupivacaine), Sodium chloride injection USP (0.9%)
NCT00479219
Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients
Alzheimer Disease
P1
Completed17RCT, Double-blindGSI-953
NCT00759564
A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function
Pneumonia
P1
Completed29Open-labelCP-70,429 and PF-03709270
NCT01314898
A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers
Healthy Volunteers
P1
Completed12RCT, Double-blind3 mg PF-03882845, 10 mg PF-03882845, 30 mg PF-03882845, 100 mg PF-03882845, Spironolactone
NCT01286454
This Is A Study Of Bioavailability And Food Effect For Fesoterodine.
Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency
P1
Completed20RCT, Open-labelfesoterodine, fesoterodine, fesoterodine, fesoterodine, fesoterodine, fesoterodine
NCT01597895
Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects
Healthy
P1
Completed14Open-labelMaraviroc, Maraviroc + Boceprevir, Maraviroc + Telaprevir
NCT07731100
A Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into the Blood in Healthy Adults
Healthy Adults
P1
Not Yet Recruiting12RCT, Open-labelPrifetrastat
NCT01250730
A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066
Healthy
P1
Completed18Open-labelPF-02341066, PF-02341066, PF-02341066
NCT01100060
A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects
Malaria Prophylaxis
P1
Completed40RCT, Open-labelazithromycin (AZ) microsphere, test chloroquine (CQ) formulation, azithromycin (AZ), chloroquine (CQ)
NCT00136968
Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy
Fungal Infection
P1
Completed12Open-labelVoriconazole
NCT07015918
A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men
Healthy Male Volunteers
P1
Completed8Open-label[14C] PF-07976016, PF-07976016, [14C] PF-07976016
NCT00038922
Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis
Ulcerative Colitis, Inflammatory Bowel Disease
P1
Terminated——rhIL-11
NCT00781794
Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients
Schizophrenia
P1
Withdrawn—RCT, Double-blindNSA-789 at 2 different doses
NCT03793439
Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis
Sarcoidosis, Pulmonary, Sarcoidosis Lung
P1
Completed5Open-labelTofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial, Corticosteroid, Tofacitinib 5mg [Xeljanz] 1 year open-label extension
NCT05489328
Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age
Pneumococcal Disease
P1
Completed394RCT, Open-label13vPnC, PCV15
NCT01199029
Single Dose Study Of PF-04308515 And Prednisone On Carbohydrate
Healthy
P1
Completed18RCT, Open-labelPF-04308515, PF-04308515, Prednisone, PF-04308515, PF-04308515, Prednisone, Prednisone
NCT01664065
A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy Subjects
Renal Disease
P1
Completed15Open-label200 mg Ceftaroline fosamil, 600 mg Ceftaroline fosamil
NCT03469336
Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis
Psoriasis
P1
Completed18RCT, Open-labelPF-06763809, Calcipotriene/calcipotriol, Betamethasone
NCT00593008
Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer
Pancreatic Adenocarcinoma
P1
Terminated5Open-labelTemsirolimus, Gemcitabine
NCT00814736
A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031
Prostatic Hyperplasia, Urinary Bladder, Overactive
P1
Completed22RCT, Double-blindUK369,003, sildenafil, sildenafil matching placebo
NCT00472927
Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro)
Postmenopause
P1
Completed—RCT, Open-labelPremarin/MPA 0.45 mg/1.5 mg
NCT02725437
Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults
Clostridium Difficile Associated Disease
P1
Completed100RCT, Double-blindClostridium difficile Vaccine, Placebo
NCT00291577
Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer
Breast Neoplasms
P1
Completed22Open-labelSunitinib (Sutent), Taxotere
NCT01707394
Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder
Thromboembolism
P1
Completed49Open-labelApixaban
NCT06675188
A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult Participants
Healthy
P1
Completed13RCT, Double-blindPF-07275315
NCT00340327
Study Evaluating IMA-638 in Healthy Japanese
Healthy
P1
Completed—RCT, Double-blindIMA-638
NCT01934569
Drug-Drug Interaction Study With PF-05089771
Healthy
P1
Completed17Open-labelPravastatin, midazolam, losartan, omeprazole, caffeine and PF-05089771
NCT03210961
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
Plaque Psoriasis
P1
Completed109RCT, Double-blindPF-06826647 tablet, PF-06826647 oral suspension
NCT02430545
Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib Pharmacokinetics
Healthy Volunteers
P1
Completed12Open-labelGlasdegib, Rifampin
NCT02006277
A Study To Taste Three New Types Of Crizotinib Formulation In Comparison Of An Oral Solution And To Measure The Amount Of Crizotinib In The Body After These Formulations Are Orally Given, Relative To Capsule Formulation
Healthy
P1
Completed21Open-labelCrizotinib prototype microsphere 0.529 mg/mg, crizotinib prototype microsphere 0.470 mg/mg, crizotinib prototype microsphere 0.420 mg/mg, crizotinib oral solution, crizotinib prototype microsphere 0.529 mg/mg, crizotinib prototype microsphere 0.470 mg/mg, crizotinib prototype microsphere 0.420 mg/mg, crizotinib capsule, crizotinib oral solution
NCT06705569
A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults
Healthy
P1
Completed22RCT, Open-labelTafamidis 61 mg free acid tablet (Test), Tafamidis 61 mg free acid capsule (Reference)
NCT03230383
A Study To Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult Subjects
Healthy Subjects
P1
Completed60RCT, Double-blindPF-06865571, PF-06865571, PF-06865571, PF-06865571, PF-06865571, PF-06865571, PF-06865571, Placebo
NCT00725582
Study Evaluating the Effect of IMA-026 on Allergen-Induced Late Asthma Response in Mild Asthma
Asthma
P1
Completed24RCT, Double-blindIMA-026
NCT01003691
Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy
Age-Related Maculopathy, Age-Related Maculopathies
P1
Completed24RCT, Double-blindRN6G, Placebo
NCT00479440
Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 in Healthy Adults
Alzheimer Disease
P1
Completed56RCT, Double-blindSAM-315
NCT00909688
Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses
Healthy
P1
Completed16RCT, Double-blindBLI-489, placebo
NCT01217918
Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects
Healthy
P1
Completed30RCT, Double-blind1 mg, 5 mg, 10 mg
NCT01054300
Effects of Once and Twice Daily Dosing Regimen of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-040)
Diabetes Mellitus, Type 2, Adult
P1
Completed52RCT, Double-blindErtugliflozin 2 mg single dose, Ertugliflozin 2 mg split into twice daily, Ertugliflozin 4 mg single dose, Ertugliflozin 4 mg split into twice daily, Placebo
NCT00596518
A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function
Renal Insufficiency, Chronic
P1
Completed30Open-labelPF-00734200
NCT05831124
A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults
Pneumococcal Disease
P1
Completed90RCT, Double-blindLow dose of multivalent pneumococcal conjugate vaccine control, Standard dose multivalent pneumococcal conjugate vaccine control
NCT01244880
Effects Of PF-02545920 On Ketamine-Induced Abnormal Prefrontal Brain Response To Associative Learning In Healthy Subjects
Healthy
P1
Terminated4RCT, Double-blindPF-02545920, PF-02545920
NCT02030483
Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma
Multiple Myeloma
P1
Terminated9Open-labelPalbociclib, Dexamethasone, Lenalidomide
NCT03267836
Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma
Meningioma, Meningioma, Adult
P1
Terminated9Open-labelAvelumab
NCT00447863
Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women
Contraception
P1
Withdrawn—RCT, Open-labelLevonorgestrel/Ethinyl Estradiol
NCT00328432
A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy
Breast Cancer
P1
Completed100RCT, Double-blindcelecoxib 400 mg bid
NCT00928551
Comparative Formulation Study of Vabicaserin
Healthy Subjects
P1
Completed15RCT, Open-labelvabicaserin
NCT02170012
A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649
Healthy Elderly
P1
Terminated24RCT, Double-blindPF-06743649, Placebo, PF-06743649, Placebo, PF-06743649, Placebo, PF-06743649, Placebo, PF-06743649, Placebo
NCT01706367
Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 Years
Clostridium Difficile Associated Disease
P1
Completed192RCT, Single-blindC. difficile vaccine, C. difficile vaccine +adjuvant, C. difficile vaccine, C. difficile vaccine +adjuvant, C. difficile vaccine, C. difficile vaccine +adjuvant
NCT04889157
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
P1
Completed20RCT, Double-blindPF-06882961, Placebo
NCT00996346
Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas
Sarcoma
P1
Terminated17Open-labelIrinotecan&Temsirolimus:Arm1, Level 1, Irinotecan&Temsirolimus:Arm 1, Level 2, Irinotecan&Temsirolimus:Arm 2, Level 1
NCT01002625
A Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers
Sleep, Healthy Volunteers
P1
Terminated18RCT, Double-blindPF-04457845 / matched placebo, PF-04457845 / matched placebo
NCT00906191
Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects
Alzheimer Disease
P1
Completed6Open-labelSAM-531
NCT00879983
An Open Label, Randomized, Crossover Study To Estimate The Pharmacokinetics And Evaluate The Safety Following A Single Dose Of Azithromycin 2g Extended-Release Powder For Oral Suspension With A 3-Day Dosing Regimen Of Azithromycin 500mg Tablet In Chinese Healthy Male Subjects
Healthy Volunteers
P1
Completed24RCT, Open-labelazithromycin (Zithromax), azithromycin (Zithromax)
NCT01948986
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
Renal Impairment, Type 2 Diabetes Mellitus
P1
Completed36Open-labelErtugliflozin
NCT05900154
A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age
RESPIRATORY SYNCYTIAL VIRUS (RSV)
P1
Completed128RCT, Open-labelRSVpreF 120 µg, RSVpreF 60 µg
NCT00867282
A Study to Estimate the Time Course of PF-00241939 Concentration in the Blood Following Dosing by Oral Inhalation From Dry Powder Inhalers
Pharmacokinetics
P1
Completed36RCT, Open-labelTreatment A, Treatment B
NCT00894660
A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects
Falciparum Malaria
P1
Completed38Open-labelAmodiaquine (Test), Amodiaquine (Comparator)
NCT01011296
First In Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Adult Volunteers
Healthy Volunteers
P1
Completed24RCT, Double-blindPF-04427429, PF-04427429, PF-04427429
NCT00999817
A Pharmacokinetic (PK) Study Of PF-00299804 And Dextromethorphan In Healthy Volunteers
Healthy Volunteers
P1
Completed14RCT, Open-labelreference [dextromethorphan], test [PF-00299804 + dextromethorphan]
NCT00369304
Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate
Healthy Subjects
P1
Completed—RCT, Open-labelpharmacokinetic (how the body absorbs and eliminates) interaction
NCT00297687
Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults
Meningitis, Meningococcal
P1
Completed108RCT, Double-blindMnB rLP2086
NCT00832806
Smoke-Free Living Study
Additional, Effective Methods to Stop Smoking
P1
Completed100RCT, Open-labelVarenicline (Champix)
NCT05654181
A First-in-human Study of Single Doses of PF-07328948 Which is Given to Healthy Adult Participants
Healthy
P1
Completed20RCT, Double-blindPF-07328948, Placebo
NCT00918164
Evaluation Of The Relative Bioavailability Of PF-04457845 Tablet To Solution Formulation And Food Effect In Healthy Subjects
Healthy Volunteers
P1
Completed12RCT, Open-labelPF-04457845
NCT02262533
Phase 1 Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects
N/A - Healthy Subjects
P1
Completed15RCT, Open-labelApixaban, Atenolol
NCT00815906
Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis
Arthritis, Rheumatoid
P1
Completed20Open-labelSBI-087, SBI-087, SBI-087, SBI-087
NCT00729833
Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Advanced Cancer, Advanced Solid Tumors
P1
Terminated45Open-labelCP-751,871, Sunitinib
NCT07009353
A Study to Learn How the Study Medicine Called [14C]PF-07054894 is Processed by the Body
Healthy
P1
Completed10Single-blindPF-07054894, PF-07054894
NCT01005472
Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
Metastatic Melanoma
P1
Completed16Open-labelsunitinib malate, temozolomide
NCT02059330
A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects
Healthy
P1
Completed27Open-labelPalbociclib 75mg, Palbociclib 125mg, Palbociclib 100mg, Palbociclib, Palbociclib 125mg
NCT04338711
A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) Formulations
Healthy
P1
Completed23RCT, Open-labeltofacitinib modified release (MR)
NCT01522807
A Study Of Three PF-05190457 Formulations In Healthy Volunteers
Diabetes Mellitus, Type 2
P1
Completed16RCT, Double-blindPF-05190457, PF-05190457, PF-05190457, PF-05190457, PF-05190457, PF-05190457, PF-05190457, PF-05190457
NCT05061277
Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Recifercept in Healthy Chinese Participants
Healthy
P1
Withdrawn—Open-labelRecifercept
NCT00800722
A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
Port Wine Stain
P1
Completed21Open-labelRapamycin Treatment of Port Wine Stain
NCT01272375
This Study Is To Estimate The Time Course Of Pf-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers
Healthy
P1
Completed48RCT, Open-labelTreatment A, Treatment B, Treatment C, Treatment D, Treatment E, Treatment F, Treatment G
NCT01649336
A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Epithelial Ovarian Cancer, Fallopian Tube Cancer
P1
Completed36Open-labelMEK162, MEK inhibitor; oral, Paclitaxel, mitotic inhibitor; intravenous
NCT01061411
Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery
Clear Cell Sarcoma of the Kidney, Recurrent Renal Cell Carcinoma
P1
Completed16Open-labelDalteparin, Sunitinib Malate
NCT05224609
A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction
Moderate Hepatic Impairment, Severe Hepatic Impairment
P1
Completed21Open-labelLorlatinib
NCT07172321
A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults
Atopic Dermatitis
P1
Completed12RCT, Open-labelPF-08049820 MR1, PF-08049820 MR2, PF-08049820 IR
NCT01396187
Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes
Diabetes Mellitus, Type 2
P1
Completed50RCT, Double-blindPF-05231023, PF-05231023, PF-05231023, PF-05231023
NCT00645463
Effect of Diltiazem Administration on CP-945,598 Pharmacokinetics
Obesity
P1
Completed28RCT, Open-labelCP-945,598, CP-945,598
NCT00716521
Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers
Methodology Study
P1
Completed11RCT, Single-blindplacebo, zolpidem, zolpidem
NCT00832052
A Study to Evaluate Safety, Tolerability, Plasma Drug Levels, and Cognitive Response Following Multiple Doses of a Drug in Healthy Elderly Participants.
Healthy, Elderly
P1
Completed32RCT, Double-blindPF-04447943, PF-04447943, PF-04447943, PF-04447943, PF-04447943
NCT04983264
A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD)
Sickle Cell Disease
P1
Completed6Open-labelGBT021601
NCT00886093
A Study To Evaluate Whether Food Affects The Plasma Drug Levels Of A 35 mg Single Dose Of PF-04447943 Taken Orally In Healthy Adult Participants
Healthy
P1
Completed10RCT, Open-labelPF-04447943, PF-04447943
NCT01129258
Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes
Diabetes Mellitus, Diabetes Mellitus, Type 2
P1
Completed110RCT, Double-blindPF-04991532, Placebo
NCT01653158
CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies
Advanced Non-Hematologic Malignancies
P1
Completed46Open-labelCP-751,871, Docetaxel
NCT00784420
Drug Interaction Study Between Raltegravir And UK-453,061
Healthy Volunteers
P1
Completed18RCT, Open-labelUK-453,061, UK-453,061, Raltegravir, Raltegravir
NCT01064726
A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response.
Allergic Rhinitis
P1
Completed18RCT, Double-blindIbuprofen, Fluticasone propionate, Placebo
NCT02767089
The Dose Response of Prednisone on Biochemical and Clinical Makers in Adult Healthy Volunteers
Healthy Adults
P1
Completed37RCT, Single-blindPrednisone, Placebo
NCT01775189
A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted
Healthy
P1
Completed45RCT, Double-blindALO-02 weight-matched placebo, crushed ALO-02 30 mg/3.6 mg, oxycodone weight-matched placebo, crushed oxycodone IR 30 mg
NCT00990015
A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers
Healthy Volunteers
P1
Completed27RCT, Double-blindPF-04308515, Placebo
NCT00147485
A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer
Neoplasms, Lymphoma, Non-Hodgkin
P1
Terminated37Open-labelAG-024322
NCT00397891
Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease
Alzheimer Disease
P1
Completed80RCT, Double-blindbapineuzumab, bapineuzumab, bapineuzumab
NCT01429740
A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults
Schizophrenia
P1
Completed29RCT, Double-blindPF-05180999, Placebo
NCT01055769
Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male Subjects
Healthy Volunteers
P1
Completed20RCT, Open-labelLinezolid, Linezolid
NCT05434091
A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult Participants
Healthy Participants
P1
Withdrawn—RCT, Double-blindPF-07291177, Placebo
NCT05650333
A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age
Alopecia Areata
P1
Completed15Open-labelRitlecitinib 20 mg
NCT06799533
A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors
Malignant Melanoma, Melanoma
P1
Terminated11Open-labelPF-08046031
NCT01034748
A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers
Carcinoma, Non-Small-Cell Lung
P1
Completed6Open-label[14C]PF00299804
NCT00857571
A Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets.
Healthy
P1
Terminated12RCT, Open-label150 mg Suspension, 30 mg Suspension, 400 mg Suspension, 5 mg Suspension, 750 mg Suspension, 150 mg Tablet, 30 mg Tablet, 400 mg Tablet, 5 mg Tablet, 750 mg Tablet
NCT02201511
A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions
Healthy
P1
Completed12RCT, Open-label3 mg PF-06412562 MR tablets_Fasted, 2 x 15 mg PF-06412562 MR tablets_Fasted, 2 x 15 mg PF-06412562 MR tablets_Fed, 10 mg PF-06412562 IR tablets
NCT04634565
PHARMACOKINETIC CHARACTERIZATION OF PF-06651600 IN CHINESE ADULT PARTICIPANTS
Healthy Participants
P1
Completed9Open-labelPF-06651600
NCT04535167
First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.
Viral Disease
P1
Completed26RCT, Double-blindPF-07304814, Placebo
NCT00630435
Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference Formulation
Menopause
P1
Completed76RCT, Open-labelPremarin®/MPA formulation A, Premarin®/MPA formulation B, Premarin®/MPA formulation C, Premarin®/MPA currently marketed product
NCT00730990
A Phase I, Healthy Volunteer Positron Emission Tomography Study
Healthy
P1
Completed10RCT, Single-blindPET Scan with PF-03654746, PET Scan with PF-03654746, PET Scan with PF-03654746
NCT00832650
Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit
Healthy
P1
Terminated60RCT, Double-blindfesoterodine fumarate, placebo, solifenacin
NCT05525910
Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants
Biological Availability, Healthy Participants
P1
Completed15RCT, Open-labelNirmatrelvir/ ritonavir, Nirmatrelvir/ritonavir, Nirmatrelvir/ritonavir, Nirmatrelvir/ ritonavir, Nirmatrelvir/ ritonavir
NCT03159117
Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma
Melanoma
P1
Completed7Open-labelPF-06688992
NCT00576589
Study Of The Safety And Pharmacokinetics Of CE-326,597 In Patients With Asymptomatic Gallstones
Obesity
P1
Completed41RCT, Double-blindCE-326,597, Placebo
NCT03685591
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Breast Neoplasms, Prostate Neoplasms
P1
Terminated49Open-labelPF-06952229, Enzalutamide
NCT01537497
A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers
Diabetes Mellitus, Type 2
P1
Completed31RCT, Double-blindPF-05175157, PF-05175157, PF-05175157, Placebo
NCT05700396
Breast Cancer Survivor Educational Intervention
Breast Cancer, Breast Neoplasms
N/A
Completed7Open-label—
NCT00579254
Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors
Hypertension and Cardiovascular Risk Factors
Terminated112—CADUET (AMLODIPINE 5 mg/ATORVASTATIN 10 mg or 20 mg)
NCT06151418
A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces
Prostatic Neoplasms
Completed2,313—Novel hormonal therapy
NCT02958527
Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE)
Depression/Depressed State
Completed1,408—venlafaxine
NCT06072196
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Prostatic Neoplasms
Completed3,017—Novel hormonal therapy
NCT00541476
Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica
Neuralgia
Completed746——
NCT05546125
a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China
Pulmonary Arterial Hypertension (PAH)
Completed100——
NCT00674687
A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing
Neuralgia, Neuralgia, Postherpetic
N/A
Completed23RCT, Double-blind2-weeks placebo then gabapentin, 1-week placebo then gabapentin
NCT01243138
Africa and Middle East Cardiovascular Epidemiological Study
Obesity, Smoking
Completed4,386——
NCT00878943
Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study
Pulmonary Arterial Hypertension
NO_LONGER_AVAILABLE——Sildenafil citrate
NCT01280747
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
Fibromyalgia, Painful Diabetic Peripheral Neuropathy
Terminated42——
NCT01773993
Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan)
Pain Associated With Fibromyalgia
Completed534—Pregabalin
NCT01441401
Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan)
Epilepsies, Partial
Completed82—gabapentin
NCT01227395
Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients
HIV Infection
Completed476—Azithromycin
NCT05034289
Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy
Clinical Trials, Immunotherapy
N/A
Completed81Open-label—
NCT01582438
An Open Label Access Study For Subjects Who Completed A1481156
Pulmonary Arterial Hypertension
NO_LONGER_AVAILABLE——Access program - sildenafil citrate, Viagra, Revatio
NCT00759174
A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
Optic Neuropathy, Ischemic
Completed673—No intervention
NCT01220180
Lyrica (Pregabalin) Korean Post Marketing Surveillance Study
Epilepsy, Neuropathic Pain
Completed4,175—pregabalin (Lyrica), pregabalin (Lyrica), pregabalin (Lyrica)
NCT00946114
To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks
Pulmonary Hypertension
Completed32—sildenafil, sildenafil
NCT00486252
Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®
Glaucoma,Open-Angle, Ocular Hypertension
Completed996——
NCT05902494
HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
Urothelial Carcinoma
Completed389——
NCT03342690
Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure)
Chronic Heart Failure
Completed1,165—Eplerenone
NCT00599768
Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.
Neuralgia, Nerve Pain
Completed325——
NCT01801982
A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN)
Pulmonary Hypertension, Persistent, of the Newborn
Completed1——
NCT05114902
PCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study
Community-acquired Pneumonia
Unknown451——
NCT01256593
Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)
Neuralgia
Completed3,827—Pregabalin (Lyrica) capsule
NCT02922179
Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics
Diabetes
Completed103,951—Long- and intermediate- acting insulins
NCT03680365
Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
Duchenne Muscular Dystrophy, Burden, Dependency
Completed60——
NCT02944344
Four Conversations RCT
Breast Cancer
N/A
Completed357RCT, Open-label—
NCT02273908
PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin
Low-Back Pain
Completed331——
NCT01206361
Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products, Duotrav And Ganfort, In The United Kingdom
Glaucoma, Ocular Hypertension
Completed2,015—XALACOM, Duotrav, Ganfort
NCT00892008
A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin
Neuropathic Pain
Completed2,278—Pregabalin
NCT00801437
Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.
Glaucoma, Open-angle
Completed457—Xalacom
NCT00584519
Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight
Schizophrenia
Completed430——
NCT01279850
Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan)
Neuropathic Pain
Completed891—Pregabalin (Lyrica) capsule
NCT00822471
Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program at an Urban Public Library
Diabetes, Cardiovascular Disease
N/A
Completed360Open-label—
NCT02922192
Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis
Rheumatoid Arthritis, Inflammatory Bowel Disease
Completed90,360—TNF-α antagonists, non-TNFs, DMARD non-biologics
NCT01792622
Patient Reported Outcomes in Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
Withdrawn———
NCT02868359
PROs in Chronic Cervical Pain Patients With Accompanying Upper Limb Radiating Pain Treated With Pregabalin
Cervical Pain, Neuropathic Pain
Completed369——
NCT01078285
Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor
Medication Non-Adherence
Completed500——
NCT00195338
Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg
Rheumatoid Arthritis
Completed25—etanercept
NCT00828945
Compliance With Treatment For Patients With Hyperlipidemia
Hyperlipidemia
Completed259——
NCT01168323
Spaced Education to Optimize Prostate Cancer Screening
Prostate Cancer
N/A
Completed95RCT, Open-label—
NCT00922987
Clinical Study With Lyrica In Patients Suffering From Epilepsy
Neuralgia, Epilepsy
Completed286—Lyrica (pregabalin)
NCT00334750
Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada
Glaucoma, Open-Angle, Ocular Hypertension
Completed410——
NCT02669771
Long-Term Specified Drug Use-Results Survey for Xtandi Capsule
Castration-resistant Prostate Cancer
Completed1,018—enzalutamide
NCT06585189
CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4]
Metastatic Non Small Cell Lung Cancer
Completed304—Pembrolizumab, Pemetrexed, Cisplatin, Carboplatin
NCT01191008
Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension
Glaucoma, Ocular Hypertension
Completed661—Latanoprost-timolol maleate fixed combination ophthalmic solution
NCT01236261
Prospective Population Study on Candidemia in Spain
Fungemia
Completed730——
NCT00866983
Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil
Pulmonary Arterial Hypertension
NO_LONGER_AVAILABLE——sildenafil (Revatio) 20 mg TID
NCT00978341
Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design
Spinal Cord Injuries
N/A
Terminated15RCT, Double-blindPregabalin, Placebo for pregabalin
NCT00270712
A Study of Factors That Affect Long-Term Kidney Transplant Function
Kidney Transplant
Completed3,175——
NCT04504201
Patient-centered Communication About Healthy Weight in Early Breast Cancer
Breast Cancer
Completed39——
NCT01607593
A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients
Posttraumatic Stress Disorder
Completed123—sertraline (Zoloft)
NCT01897740
Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil
Pulmonary Arterial Hypertension
NO_LONGER_AVAILABLE——sildenafil
NCT00709787
Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management
Hypertension
Completed899——
NCT00605813
Special Investigation Of Long Term Use Of Sertraline.
Depression, Panic Disorder
Completed542—Sertraline hydrochloride
NCT04836221
Comorbidities And Reducing inEquitieS
Cancer, Breast, Diabetes Mellitus
N/A
Completed63Open-label—
NCT04175262
Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments
Metastatic Renal Cell Carcinoma (mRCC)
Completed102—sunitinib
NCT00666198
Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)
Pulmonary Hypertension
Completed3,337—SILDENAFIL
NCT02380274
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
Prostate Cancer, Castration-resistant Prostate Cancer
Completed1,030——
NCT00579670
Treatment of Schizophrenic Patients With Ziprasidone
Schizophrenia
Completed450—Ziprasidone
NCT01053429
A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule
Bipolar Disorder, Schizophrenia
Completed3,391—ziprasidone
NCT00768573
Taste Test of a New Formulation of Sildenafil (Revatio)
None Volunteer
Completed4—sildenafil
NCT02530944
Web-based Genetic Research on Lupus
Systemic Lupus Erythematosus
Completed5,000——
NCT04076787
Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib
Metastatic Renal Cell Carcinoma
Completed1,769—Sunitinib
NCT01150903
Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor
Erectile Dysfunction, Cardiovascular Diseases
Completed98,832——
NCT00567268
Drug Use Investigation Of Gabapentin
Epilepsies, Partial
Completed1,273—Gabapentin
NCT02870296
Anticoagulation Medical Home
Venous Thromboembolism, Patient-Centered Care
N/A
Completed162RCT, Open-label—
NCT05438888
Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data
Non-valvular Atrial Fibrillation
Completed77,814—Warfarin, Apixaban
NCT02322580
An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients
Psoriasis
Completed56—etanercept
NCT04609319
Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review
Lung Cancer
Completed307—Dacomitinib
NCT02454530
Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study
Chemotherapy-Induced Neutropenia
Terminated1,160—Nivestim®
NCT04435769
Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment
Atrial Fibrillation
Completed109——
NCT03276754
Immunization To Prevent Acute COPD Exacerbations
Pneumococcal Infections, COPD
Terminated530——
NCT00293722
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
Arthritis, Psoriatic, Psoriasis
Completed1,308—Etanercept
NCT01329783
EuroSIDA As An External Comparator To MOTIVATE Trials
HIV, AIDS
Completed1,181——
NCT00338741
Rebif® Pregnancy Registry
Multiple Sclerosis
Completed36——
NCT00002305
A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis
Meningitis, Cryptococcal, HIV Infections
N/A
Completed——Flucytosine, Fluconazole, Amphotericin B
NCT00258869
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
Sepsis, Septicemia
Unknown1,200——
NCT04176354
Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy
Metastatic Breast Cancer
Completed813—Palbociclib + an aromatase inhibitor, Palbociclib + Letrozole, Letrozole
NCT02789137
Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment
Metastatic Renal Cell Carcinoma
Completed111——
NCT01648751
Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse
Pelvic Organ Prolapse
N/A
Terminated21RCT, Double-blindVaginal estrogen, Placebo
NCT01747369
Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
Pneumonia, Bacterial, Pneumonia, Viral
Unknown2,000——
NCT05452798
A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark
Breast Cancer
Completed1,054——
NCT00770887
Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate
Fertility
Completed50——
NCT00929721
A Global Active Surveillance for Community Acquired Pneumonia
Community Acquired Pneumonia
N/A
Completed5,172Open-label—
NCT00002306
A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B
Meningitis, Cryptococcal, HIV Infections
N/A
Completed——Fluconazole
NCT00329069
The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia
Coronary Artery Disease, Hypercholesterolemia
N/A
Completed50RCT, Double-blindatorvastatin (drug)
NCT00697112
Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD)
Renal Transplantation
Completed53—Sirolimus
NCT00488475
Observational Trial With Enbrel
Rheumatoid Arthritis
Completed4,945—etanercept
NCT02539368
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Ulcerative Colitis
Completed2,565—CT-P13, Remicade
NCT00754260
Caffeine Reduction and Overactive Bladder Symptoms
Overactive Bladder
N/A
Terminated42RCT, Single-blind—
NCT00845273
Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration
Macular Degeneration
Completed3,538—Pegaptanib sodium
NCT01981473
Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab
Rheumatoid Arthritis
Completed605——
NCT04744454
Post Marketing Surveillance (PMS) Study of Cresemba in Korea.
Aspergillosis, Mucormycosis
Completed94—Isauvuconazole group
NCT04428424
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
Arthritis, Rheumatoid
Completed1,493—Enbrel
NCT01790828
Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A
Hemophilia A
Completed42—Xyntha : coagulation factor IIIV (recombinant)
NCT01414257
Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan)
Arthritis, Rheumatoid
Completed2,860—Methotrexate (MTX)
NCT06634836
Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B
Hemophilia A, Hemophilia B
Withdrawn———
NCT00943735
This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder
Overactive Bladder
Completed774—Fesoterodine
NCT02432430
Comparison of Immunization Quality Improvement Dissemination Study
Immunization, DTaP Vaccine
N/A
Completed2,186RCT, Single-blind—
NCT03375242
Safety and Efficacy of Xalkori ROS1
Non-small Cell Lung Cancer
Completed97—crizotinib
NCT00465894
Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms
Overactive Bladder
N/A
Completed58RCT, Open-labelExtended Release Tolterodine LA, Intra Vaginal Estradiol Cream
NCT05372575
A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSIS
Immunogenicity, Vaccine
N/A
Completed300Open-labelPCV13 PAC study
NCT00002294
A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS
Meningitis, Cryptococcal, HIV Infections
N/A
Completed—Double-blindFluconazole
NCT02531061
Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy
Rheumatoid Arthritis
N/A
Completed35Open-label—
NCT05269069
Impact of Rheumatoid Arthritis on Body Composition, Bone Marrow Adiposity and Bone Mineral Density: a Case-control Study
Rheumatoid Arthritis
Terminated52——
NCT00505297
A Longitudinal Study of Osteoarthritis (OA) Disease Progression Measured by MRI, dGEMRIC, and Radiography
Osteoarthritis
Completed18——
NCT00576576
Evaluation of Atorvastatin on Atherosclerosis Composition
Atherosclerosis
N/A
Completed27Open-labelAtorvastatin
NCT04613375
PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older
Community Acquired Pneumonia (CAP)
Completed1,821——
NCT00564174
Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT
Recurrent Pregnancy Loss, Antiphospholipid Antibody Syndrome
N/A
Terminated88RCT, Open-labelLow molecular weight heparin and low dose aspirin, Low dose aspirin
NCT00002090
An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)
Mycobacterium Avium-Intracellulare Infection, HIV Infections
N/A
Completed——Azithromycin
NCT07235397
Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset
Respiratory Syncytial Virus Infections
Not Yet Recruiting1—ABRYSVO
NCT05471505
Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding
Non-valvular Atrial Fibrillation
Completed120,722——
NCT00288366
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
Schizophrenia, Schizoaffective Disorder
N/A
Completed49RCT, Open-labelziprasidone vs. aripiprazole, aripiprazole vs. ziprasidone
NCT00823966
Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients
HIV-1 Infection
Completed3—Rescriptor
NCT01073644
Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients
Metastatic Renal Cell Carcinoma
Terminated3—Sunitinib malate
NCT02461602
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Atrial Fibrillation
Completed251——
NCT03220230
Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.
Lung Neoplasms
Completed4,240——
NCT00749320
Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)
Renal Cell Carcinoma
N/A
Completed32Open-label—
NCT00167973
Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use
Hemophilia B
Completed218——
NCT04647110
Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers.
ALK-positive NSCLC
Completed549—crizotinib, alectinib, brigatinib, ceritinib, lorlatinib
NCT01260311
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
Over Active Bladder
Completed508—Fesoterodine
NCT01363271
Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients
Complicated Skin and Structure Infection, Nosocomial Pneumonia
Completed7,260—Linezolid, Vancomycin, Linezolid, Vancomycin
NCT06688838
Effective Treatment of Jak1/3 Inhibitor in Blau Syndrome
Blau Syndrome
By Invite24—Tofacitinib
NCT02264665
OPALINE : A Study Of Morbidity And Mortality At 2 Years
Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive
Completed144—sunitinib, everolimus, chemotherapies recommended in france
NCT05568407
A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer
Bladder Cancer
Terminated19—Avelumab
NCT03105271
Acute Kidney Injury in Patients With Sickle Cell Disease
Sickle Cell Disease, Kidney Injury
Completed60——
NCT03096509
Participatory Action Research to Evaluate the Delivery of the MISSION ABC Service Model and Assess Health Service and Clinical Outcomes
COPD, Asthma
Completed342——
NCT01396434
Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos
Pneumococcal Disease
Completed3,006—Prevenar 13
NCT00444899
Clinical and Economic Benefits of Cardiovascular Risk Management by a Dietician in Type 2 Diabetes Patients
Type 1 Diabetes, Type 2 Diabetes
N/A
Completed101RCT, Open-label—
NCT07527832
An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.
Colorectal Cancer
Completed1,000—Bevacizumab-Pfizer Biosimilar, Avastin
NCT03812835
A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment
Thrombosis, Deep Vein, Pulmonary Embolism
Withdrawn———
NCT00396474
Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height
Infant, Small for Gestational Age
Withdrawn———
NCT05597085
A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment
Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
Completed32—Inotuzumab Ozogamicin
NCT00884468
Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis
Psoriatic Arthritis
Completed384——
NCT01326468
Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer
Head and Neck Cancer
N/A
Withdrawn—Open-labelTemsirolimus, Cetuximab, Cisplatin
NCT00378989
The Effectiveness of Health Advice and Occupational Health Intervention on Work Ability
Signs and Symptoms
N/A
Completed418RCT, Single-blind—
NCT01707576
Screening of Adolescent Mental Suffering
Depression, Adolescent
N/A
Completed346Open-label—
NCT00902785
A Study Of Early Markers Of Choroidal Neovascularization
Choroidal Neovascularization (CNV), Age-related Macular Degeneration (AMD)
Terminated100——
NCT00438555
Randomized, Controlled, Open, Comparative Intervention Study for Obesity Prevention in Children
Obesity
N/A
Completed248RCT, Open-label—
NCT02188667
Integrating Patient Reported Outcomes (I-PRO) Study for Multidisciplinary Pain Care
Chronic Noncancer Pain
N/A
Completed21RCT, Open-label—
NCT02192164
Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis
Plaque Psoriasis
Completed126——
NCT00163618
Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children
Encephalitis, Tick-borne
Completed——Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
NCT01617018
Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis
Psoriasis
Completed4,613——